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 Abstract 
Several co-culture systems incorporating fibroblasts and endothelial cells have been used to 
characterize cell-cell and cell-matrix interactions critical for angiogenesis in wound healing. 
However, these models do not provide a means for translation into therapies for chronic non-
healing wounds. We developed an approach that may facilitate in vivo neovascularization 
utilizing the advantages of both proangiogenic co-culture and collagen microthreads. This system 
could also serve as an in vitro tool to study angiogenic mechanisms. After design validation pilot 
studies, self-assembled collagen microthreads populated with human dermal fibroblasts (HDFs) 
were extruded using a novel method. Human umbilical vein endothelial cells (HUVECs) were 
then seeded on the surface of the HDF-populated collagen microthreads. Fluorescence 
microscopy confirmed the presence of both cell types after 48 hours of co-culture, and phalloidin 
staining was used to visualize cell morphology. These results demonstrate that co-culture can be 
established on a collagen microthread platform with these seeding methods, and that this system 
is viable after 48 hours of co-culture. Future studies of these co-cultured constructs should 
investigate their cellular interactions, angiogenic potential, mechanical properties, and 
implantation feasibility. 
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1. Introduction 
Ischemia-related diseases, such as cardiovascular disease and chronic wounds, are prevalent 
medical issues, affecting over 80 billion patients and costing over $480 billion annually [1, 2].  
These diseases are characterized by tissue death, insufficient blood flow, and diminished 
functionality. Many groups have investigated potential treatments for these diseases. Among 
these treatments are options for cell delivery to the injured tissue. For example, cardiac ischemia 
or infarction might be treated with cardiomyocytes or skeletal myoblasts [3, 4]. It has been found 
that these therapies demonstrate distinct benefits over some traditional treatments. In particular, 
the formation of new blood vessels through angiogenic pathways has emerged as a potentially 
effective solution for these diseases [5]. 
The enhancement of angiogenesis toward more efficient and complete wound healing has 
been studied extensively both in vivo and in vitro. Physiological angiogenesis occurs through a 
highly-regulated cascade of endothelial cell activation, migration, proliferation, and tubule 
formation whereby new vasculature sprouts from pre-existing vessels [6]. Though endothelial 
cells play a critical role in neovascular formation, the delivery of endothelial cells (ECs) alone is 
not sufficient because the cells are not presented with the full complement of environmental cues 
required for proper angiogenesis [7]. A number of angiogenic and angiostatic growth factors are 
required for angiogenesis to occur [8, 9]. In vivo, periendothelial cells including fibroblasts serve 
as an abundant source of such angiogenic factors, activating ECs, promoting EC cell-cell contact, 
and directing angiogenesis [10]. Further, these cells produce extracellular matrix proteins that 
provide structural and biochemical support for the neovasculature [11]. 
Several groups have developed co-culture systems consisting of these two cell types to assess 
the role of each in angiogenesis. Using a co-culture model system with endothelial cells and 
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fibroblasts in a collagen gel, such studies have demonstrated induced angiogenesis in vitro as 
evidenced by EC activation, migration, and the formation of tube-like structures [6]. These 
models used collagen hydrogels and sponges to provide essential three-dimensional support and 
signaling templates for cellular interactions. However, the effectiveness of such scaffolds may be 
restricted by generally poor mechanical properties, limited mass transport, and an inability to 
translate directly to clinical application [12]. As such, there remains a need for an adequate 
delivery platform that will facilitate guided angiogenesis in a medical context. 
Previously, small diameter fiber scaffolds derived from natural polymers have demonstrated 
improved mechanical strength as well as the ability to facilitate contact guidance, alignment, and 
orientation of cells [13]. These scaffolds can be composed of various biomaterials, such as 
collagen, and have been shown to endure in vivo implantation. 
This basic principle was adapted into a novel extrusion method to enable and facilitate the 
embedding of cells within the microthread. Human dermal fibroblasts (HDFs) were co-extruded 
with a collagen suspension, creating HDF-populated microthreads. Cell seeding on a cylindrical 
surface provides a number of challenges, so a custom-built PDMS seeding device was created to 
provide constrained volume and geometry. This device promotes cell contact and adhesion to the 
curved microthread surface. Human umbilical vein endothelial cells (HUVECs) were seeded 
onto the surface of the collagen microthread using this device. 
HDF-HUVEC co-cultured threads were characterized using fluorescent microscopy. 
Phalloidin was used to visualize cell morphology, and Hoechst was used to identify cell nuclei. 
To differentiate between the two cell types, the HUVECs were pre-loaded with DiI-ac-LDL, an 
endothelial cell-specific dye. Visualization using fluorescence microscopy was used to verify the 
spatial location of the cells as well as to determine viability based on cell morphology over 
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extended culture periods. All fluorescent images of the co-culture samples confirmed the 
presence of HDFs within, and HUVECs on the threads at all time points. Changes in HDF and 
HUVEC morphology were observed in both mono- and co-cultured threads as a function of time. 
The developed technology, particularly the methods to independently seed two cell types, 
could also be utilized to construct threads for housing and studying other co-culture systems, not 
just pro-angiogenic ones. This opens up countless possibilities for creating easily deliverable 
cellular therapies and studying other in vivo physiologic mechanisms. 
In the subsequent chapters, this project will elaborate on the importance of angiogenesis in 
wound healing, our project strategy, and alternative designs and verification. It will provide a 
discussion of results and the final design validation. It will also contain conclusions based on the 
analysis of the system, and recommendations for future work. 
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2. Literature Review 
2.1 Clinical Motivation  
2.1.1 The Problem 
Ischemia occurs with insufficient blood supply or blood flow to a part of the body. This lack 
of oxygen and nutrients can lead to tissue damage or dysfunction [14, 15]. Ischemia is caused by 
the narrowing or restriction of blood vessels, which can be triggered by various sources 
including atherosclerosis, thrombosis, blood clots, diseases such as sickle-cell disease and 
peripheral vascular disease, congenital heart defects, and tachycardia. This lack of perfusion also 
occurs in chronic wounds, especially venous ulcers, diabetic ulcers, and pressure ulcers [16]. 
Major types of ischemia include cardiac, cerebral, mesenteric and cutaneous ischemia.  
Infarction involves the death of tissue caused by a lack of perfusion to the tissue (ischemia). 
In a myocardial infarction, this is usually due to blockage in a coronary artery. After 20 to 40 
minutes of severe ischemia, irreversible necrosis, or tissue death, will occur. The dead tissue is 
eventually replaced by scar tissue, which in some tissues, especially the heart, restricts operation 
and functionality [17]. An illustration of this is shown in Figure 1. 
 
Figure 1: Myocardial Infarction Cross-Section. An example of a myocardial infarction shown in cross-section of the heart 
(ventricles only) with zone of infarction, zone of injury, and zone of ischemia. Image from http://medical-dictionary. 
hefreedictionary.com/venous+infarction. 
In the case of a myocardial infarction, the dead myocardium and the resulting scar tissue 
cause ventricular fibrillation, which greatly impacts the functionality of the heart. Large amounts 
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of dead or scar tissue can lead to heart failure, as this tissue does not contract with the healthy 
heart tissue and leads to reduced blood flow. Ventricular fibrillation is a condition in which the 
heart cannot send normal electrical impulses to stimulate contraction, as the scar tissue is too 
prevalent, and instead the heartbeat becomes erratic and eventually stops, leading to death. The 
heart cannot sufficiently supply blood to the rest of the body promoting systemic ischemia. 
Diminished blood flow can contribute to additional cardiac ischemia and myocardial infarction 
by restricting the availability of oxygen and nutrients to the tissue, and can lead to failure in other 
organs, as well as brain damage and death [18]. 
 
2.1.2 Current Solutions 
As lack of perfusion and the resulting tissue necrosis are widespread concerns that affect 
numerous areas of medicine, many treatments have been developed to address these conditions, 
specifically the causes and effects of dead tissue in the heart and the lack of blood flow to cells. 
Medications, surgical methods, and cellular therapies are currently in use as treatments. 
Pharmaceuticals 
Many pharmaceuticals have been developed to address the effects of ischemia and infarct, 
specifically the lack of blood to the injured tissue. For example, Angiotensin-Converting Enzyme 
(ACE) inhibitors work by blocking an enzyme responsible for the narrowing of blood vessels. 
With this enzyme blocked, vessels stay open and blood pressure is decreased; however 
respiratory complications are common, making this drug unsuitable for anyone with a pre-
existing respiratory condition. A classification of medication known as vasodilators, such as 
nitroglycerin and other nitrates, widen and relax blood vessels to improve blood flow and allow 
more oxygen to reach ischemic tissues. This type of drug has few serious side effects, but 
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requires fastidious attention to other conditions and medications. Anti-platelet and anti-coagulant 
medications, commonly called ―blood thinners‖, are also prescribed to treat some conditions that 
can cause ischemia and infarction. Unfortunately, only a fraction of patients will have conditions 
that are treatable by this method, and there is a significant risk for the development of bleeding 
problems [19]. 
Surgical Methods 
The percutaneous transluminal angioplasty (PTA) is a procedure used specifically in 
situations where plaque is the main cause of decreased blood flow. A balloon catheter is 
surgically inserted into an artery and is expanded. This action compacts the plaque into the wall 
of the artery and allows blood to flow freely. Often, this procedure is accompanied by the 
implantation of a stent, a small mesh-like tube, which holds the plaque against the artery wall, as 
shown in Figure 2. This process is potentially dangerous as the site of insertion of the PTA 
catheter can become infected, and the stent can also damage blood vessels around it [20]. In 
addition, this process has a limited success rate, as narrowed vessels have a 25% chance of 
recurring in the three to six months after surgery, especially in the presence of excessive scar 
tissue [21]. 
 
Figure 2: Balloon Catheter and Stent Deployed. The figure demonstrates the insertion and use of an arterial stent. 
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The artery bypass graft is another surgical procedure similar to PTA. Instead of an external, 
biocompatible synthetic, a small section of artery from another point in the body is grafted into 
the tissue. This surgery is, like the PTA, risky as it involves a major operation, and is therefore 
restricted to patients healthy enough to undergo invasive surgery [22]. 
Cellular Therapy 
Cellular therapies are utilized to treat ischemic tissue and infarctions. The introduction of 
cells to the ischemic or infarcted tissue has been found to improve function by restoring the dead 
or injured tissue with new cells or by restoring perfusion to the injured tissue with the creation of 
neovascular structures. For example, a study, performed by Perin et al., was conducted with 
patients suffering from end-stage ischemic heart failure and followed the long-term effects of 
injection of bone marrow cells to the ischemic tissue. This study concluded that the introduction 
of these cells to the tissue delivers a long-term therapeutic effect through improved myocardial 
perfusion and regional contractility [23]. 
Currently, the most prevalent method for cell delivery is injection, either into the circulatory 
system through intravenous (IV) transport or directly into the injured tissue [24]. During 
intravenous transport, a solution of cells is prepared and introduced into the body through an IV. 
The cells travel through the circulatory system and make their way to the injury, where they will 
engraft to ischemic or infarcted tissue. This method has many flaws, including cell clumping and 
a slow rate of infusion [25]. In addition, there is no way to guarantee that the cells will localize to 
the targeted tissue. For example, introduced cardiac cells have been found in the spleen, kidney, 
and liver, and the lungs [25]. Direct injection of cells into the affected tissues can be 
accomplished in several ways. Some direct injection procedures, such as intracardiac injection, 
can be minimally invasive, as cells are injected through skin and muscle tissue into the injury 
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without surgery. A second procedure utilizes endoscopy, in which a tube that can be manipulated 
to access the injury and allows entry of medical instruments is inserted into the body, as a 
minimally invasive injection mechanism. A third method of direct injection is performed during 
surgery, in which a surgeon determines where the cells should be injected [24]. 
Despite successes in previous studies, direct injection of any kind has significant risks. Direct 
injection through the intervening skin and muscle layers has a long list of complications, such as 
the risk of additional damage within the tissue itself from the introduction of the needle as well 
as the risk to surrounding organs and tissues. Endoscopic procedures are not able to access all 
affected tissues, and endoscopy has additional risk of complications such as pain, bleeding, or 
infection, or perforations in the intermediate tissues [26]. While a more direct and specific 
approach to injection, this method does include all the risks of major surgery, including 
complications and death. Also, injected cells usually do not have sufficient ability to migrate, 
reducing the range of possible tissue repair and decreasing the effectiveness of these methods in 
large ischemic or infarcted areas [24]. 
With both intravenous transport and direct injection, it has been demonstrated that less than 
3% of introduced cells will engraft to the site of the injury due to the delivery procedure [24]. 
From these results, we can conclude that delivery of therapeutic cells to injured tissue is has 
positive effects on cardiac tissue. However, the cell delivery method still reminds to be a 
problem needed to be addressed. 
2.2.1 Biomaterial Scaffolds 
Biomaterial scaffolds have been investigated to address the need, left by the previously 
discussed injection methods, for more effective and economical delivery of cells to injured 
tissue. Throughout the body, the biochemical and mechanical interplay between cells and their 
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underlying matrix are of paramount importance to the development, functioning, and repair of 
tissue. Therefore, in building engineered tissue constructs, which are fabricated by coupling 
isolated tissue-specific cells with biomaterial scaffolds, we seek to recreate the natural conditions 
of the cellular microenvironment as closely as possible. To achieve this, the biochemistry and 
structural organization of biomaterial scaffolds have been precisely controlled, which directs 
cellular attachment, proliferation, and ordered development [27]. Several crucial requirements of 
implantable scaffolds for tissue engineering have been identified [28, 29]: 
i. Biodegradability with tunable degradation rate matching that of new tissue 
deposition. 
ii. Biocompatibility through all stages of degradation. 
iii. Mechanical properties analogous to native tissue throughout the regeneration process. 
iv. Biofunctionality – the ability to support cellular proliferation and differentiation of 
both implanted and native cells, ECM secretion, and the formation of functional 
tissue. 
Naturally derived polymer hydrogels have been characterized for use in several tissue 
engineering applications because they have macromolecular properties similar to – or in some 
cases, identical to – the native ECM [30]. Materials such as collagen, fibrin, alginate, chitosan, 
HA, and silk demonstrate highly desirable intrinsic biocompatibility and biofunctionality and 
have been studied extensively as scaffolds for engineering connective tissues, skin, muscle, and 
several other types of tissue. In particular, the collagens, which are the most abundant proteins in 
the extracellular matrix of mammalian tissues [31], have shown exceptional potential as 
biomaterial scaffolds. Originally used as delivery vehicles for cultured skin cells and therapeutic 
drugs in skin replacement and burn wound applications [32], collagen scaffolds have more 
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recently been used in bioengineered tissues such as blood vessels, heart valves, and ligaments 
[33]. While collagen films, hydrogels, and sponges provide essential three-dimensional support 
and signaling templates for regenerating tissue, the effectiveness of such collagen based 
scaffolds for tissue engineering is restricted by generally poor mechanical properties [12]. 
Fibrous scaffolds with controllable, well-characterized mechanical properties have been 
produced from several naturally derived biomaterials including fibrin, silk, and collagen. The 
original motivation for this type of biomaterial scaffold was to promote regeneration of tendons 
and ligaments; Kato et al. found that fibers extruded from type I collagen demonstrated 
mechanical, structural, and biochemical homology to native tendon and ligament [34]. Studies 
have shown that cylindrical substrata of less than 100 µm (i.e. fiber based scaffolds) facilitate 
contact guidance, alignment, and orientation of cells as well as regeneration-focused cell 
functions such as ECM deposition [35, 36]. In addition to mimicking native tissue and enhancing 
tissue regeneration, fiber-based scaffolds, such as collagen microthreads, have demonstrated an 
ability to be bundled, woven, or braided into larger, more complex structures [13, 37]. It has 
been shown that bundled structures of silk fiber scaffolds increase surface area for cell 
attachment and ECM deposition while minimizing mass transfer limitations [38]. Several groups 
have used cell-seeded fibrous scaffolds as delivery vehicles for cells as well as bench-top model 
systems to characterize cell-matrix interactions [13, 37]. 
 
2.2.2 Cellular Co-culture 
Though these previously studied scaffolds have yielded generally positive results, most cell 
delivery and tissue engineering approaches have focused on systems incorporating a single cell 
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type. However, in vivo tissues consist of multiple cell types influenced by each other through 
cell-cell interactions. 
In vivo, cells reside in a highly interactive environment. The phenotype, function, and 
behavior of one cell type are affected by other cell types in the body. These cellular interactions 
have been largely studied in recent years. The general types of cell-cell interactions are described 
in Figure 3 [39]. 
 
Figure 3: Classification of Cell Interactions in Co-Culture. Cell interactions in co-culture can be classified into several 
distinct categories [39]. A: The two cell types interact to promote their respective physiological function or differentiation. B: 
One cell type promotes the physiological function or differentiation of a second cell type. C: One cell type influences a second 
cell type to transdifferentiate into lineage similar to that of the first. D: The first cell type influences the second cell type to 
differentiate to a lineage different from either of the two original cell types. E: One cell type inhibits the differentiation of a 
second cell type. Figure and caption adapted from [39]. 
Engineered tissue constructs, fabricated by coupling cells with biomaterial scaffolds, seek to 
mimic the natural conditions of the cellular microenvironment as much as possible. Specific 
tissues are designed as in vitro models for controlled analysis of cell function and tissue 
development under normal and compromised conditions. A common method of better mimicking 
the in vivo environment is cellular co-culture. This involves the culturing of two cell types in the 
same microenvironment. According to Hendriks et al. [39], co-culture is utilized in tissue 
engineering to create a multi-cellular tissue or organ replacement to maintain and support each 
cell type‘s specific lineage 
While co-culture systems were initially used to study cell-cell interactions, they are 
becoming increasingly common tools in creating tissue models as they provide several 
advantages over single-cell type models. Since natural tissues are mostly multi-cellular, co-
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culture approaches to engineering tissues can be used as an effective culture environment to 
generate grafts that will more precisely mimic the natural development of the tissue. 
 
2.3 Angiogenesis 
2.3.1 Angiogenesis in Wound Healing 
The formation of new blood vessels, either through angiogenesis or vasculogenesis is an 
essential part of wound healing. It is required so that the new tissue receives proper perfusion of 
oxygen and nutrients. Wound healing can be divided into four distinct phases: coagulation, 
inflammation, proliferation, and remodeling. Coagulation involves clot formation to seal off the 
wound area, fibrin synthesis, and the release of cytokines that activate the next phase. 
Inflammation, typically starting shortly after injury and lasting for a few days involves vascular 
dilation, leukocyte arrival at the wound site, and formation of granulation tissue. Granulation 
tissue is highly vascular due to the occurrence of vasculogenesis and angiogenesis during its 
formation. Following this is the proliferation phase, characterized by fibroblast proliferation and 
scar tissue formation. This replaces much of the granulation tissue with scar tissue. Remodeling 
ensues in which a balance of collagen synthesis and degradation is established to provide scar 
tissue with its characteristic mechanical properties [40]. 
The large role that vasculogenesis and angiogenesis play in wound healing has made it a 
primary target of research in the field of both chronic and ischemic wounds. Essential to 
developing a greater understanding of angiogenesis is the establishment of relevant accessible in 
vitro models [41, 42] based on the in vivo mechanisms of the process. From a tissue engineering 
perspective, translation of these models into therapeutic treatments is a critical goal [43]. 
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2.3.2 In vivo Mechanisms 
The formation of new blood vessels is known as neovascularization and can be divided into 
two categories: vasculogenesis and angiogenesis. Vasculogenesis is the de novo formation of 
new blood vessels, while angiogenesis is the formation of new capillaries from preexisting blood 
vessels [40, 44]. The process of angiogenesis involves the cooperation of a stromal cell layer, 
such as fibroblasts, in conjunction with endothelial cells as driven by a complex signaling 
cascade. This co-culture system involves two cell types (Figure 4). This process as it occurs in 
vivo can be summarized and divided into several distinct steps (adapted from [42]):    
1. Stimulation of endothelial cells via growth factor and cytokine binding to cell receptors  
2. Expression of a specific profile of matrix degrading enzymes (proteases, MMPs, 
TIMPs, etc.) and matrix remodeling 
3. Proliferation and migration of endothelial cells  
4. Differentiation of endothelial cells and tube-like structure formation  
5. Pericyte and smooth muscle cell (SMC) stabilization of new vessel structures  
Activation of angiogenesis involves the stimulation of endothelial cells via growth 
factors and cytokines released from platelets, SMCs, monocytes/macrophages, and fibroblasts 
[40]. This induces the endothelial cells to produce specific proteases including MMPs, TIMPs, 
serine proteases, and urokinase plasminogen activator. The profile of proteases produced 
depends on the composition of the ECM that the endothelial cells are exposed to upon initial 
digestion of the basement membrane. The breakdown of the ECM allows the endothelial cells to 
migrate and proliferate. Migration of the endothelial cells is driven by a cytokine gradient and is 
mediated primarily by cell adhesion [40]. Following migration, the endothelial cells 
eventually differentiate and form tube-like structures through mechanisms that are poorly 
understood.  
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Figure 4: The Process of Angiogenesis. 
 
2.3.3 Emulating Angiogenesis Strategies in vitro 
Models of angiogenesis are used for several purposes. Uses of these models include but are 
not limited to elucidation of how the angiogenesis process works, developing pro-angiogenic 
therapeutics, and developing methods of angiogenesis inhibition to treat tumors [44]. In 
vitro models of angiogenesis seek to closely mimic the steps of the process as it occurs in 
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vivo. In 1997, Jain et al. described the ideal angiogenesis model which included the following 
(adapted from [44]): 
1. Known release rates, spatial and temporal concentrations, and distributions of 
angiogenic factors and inhibitors for forming dose-dependent curves.  
2. Ability to quantify the structure of the new vasculature.  
3. Ability to quantify endothelial cell migration and proliferation, etc.  
4. Confirm in vitro responses in vivo.  
In vitro angiogenesis models are usually based around the culturing of endothelial cells, as 
they are the primary cell type required for the process to occur [45]. There are two main types of 
in vitro angiogenesis models: organ culture models and cell culture models. Organ culture 
models most often involve the isolation and culture of rat aortic ring or chick aortic arch 
followed by quantification of endothelial cell outgrowth. The advantage of organ culture models 
is that the endothelial cells are cultured with native stromal cells, which better emulates the in 
vivo environment [44]. Cell culture models range from 2-D culturing of endothelial cells on 
ECM-coated surfaces to co-culture systems of endothelial cells and fibroblasts seeded in 3-D 
matrices. 
From a tissue engineering perspective, one effective method of modeling angiogenesis in 
an in vitro cell culture model is through co-culture in an attempt to better mimic the environment 
that endothelial cells are exposed to during angiogenesis in vivo. Most angiogenesis co-culture 
models include endothelial cells and a supporting stromal cell type (fibroblasts, smooth muscle 
cells, etc.) [44]. Fibroblasts appear to be the most widely used stromal cell type for this particular 
co-culture variation. In addition, an ECM-based scaffold is often included to help further emulate 
the in vivo environment. This particular co-culture model of endothelial cells and fibroblasts has 
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shown many advantages over single culture of endothelial cells. Some widely observed 
advantages include:  
 Increased tubule / tube-like structure formation [42, 43, 46] 
 Decreased endothelial cell apoptosis rates with lowered proliferation activity [41, 43, 47] 
 Increased endothelial cell migration [6] 
 Expression of specific MMPs, TIMPs, proteases, and growth factors involved 
in angiogenesis [46, 48] 
 
2.4 Scientific and Engineering Need 
Increased perfusion assists in the restoration of functionality in ischemic tissues. For 
example, Hasche et al. conducted a study that compared the time for which a human subject 
suffered from cardiac ischemia to the resulting infarction size and subsequently to the heart‘s 
ability to function at a sufficient level. By inducing perfusion of ischemic tissues through 
therapeutic angiogenesis, it may be possible to enhance wound healing and tissue function [17]. 
In ischemic wounds and infarcted tissue, perfusion is inadequate and the process of angiogenesis 
is disrupted [49], eliminating the ability of such wounds to repair themselves since 
revascularization must occur before proper wound healing can take place. Therefore, there is a 
need for the development of novel clinical therapies for patients who suffer from tissue ischemia. 
Because most of the comorbidities associated with delayed healing and chronic wounds 
result in tissue-level impairment of microcirculation, traditional large-scale revascularization 
strategies including surgical bypass, angioplasty, and stent procedures are not effective [40]. 
Alternative clinical approaches to enhance wound healing by means of neovascularization are 
needed. Treatment options that aim to stimulate neovessel formation and wound healing at the 
cellular level have shown some promise. However, despite the critical role of endothelial cells in 
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neovascular formation, stromal cell layer such as fibroblast is required to be presented with the 
full complement of environmental cues that are required for proper angiogenesis [7]. 
Temporal, spatial, and dose-controlled exposure to a number of angiogenic and angiostatic 
growth factors is required for proper angiogenesis, and thus wound healing, to occur [8, 9]. As 
previously discussed, several groups have developed in vitro models consisting of fibroblast- 
endothelial cell co-culture on biomaterial scaffolds that emulate angiogenesis. However, these 
pro-angiogenic co-culture systems have not yet been translated to clinical therapies, and effective 
translation will require a delivery vehicle to direct angiogenesis. 
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3. Project Strategy 
The goal of this project was to use biopolymer microthreads as a platform for delivering two 
cell types to promote angiogenesis. To best accomplish this goal, it would be necessary to 
combine the advantages of two technologies: pro-angiogenic co-culture and biomaterials-based 
delivery systems. This task presented a number of engineering challenges that would ultimately 
need to be overcome. This chapter will provide an overview of the strategic design process that 
was performed to first determine and then prioritize the design objectives. The final section of 
this chapter will discuss the broad approach that the design team developed to satisfy the client 
statement and achieve the design objectives. 
 
3.1 Design 
This section will describe in detail the process of designing a co-culture system on 
biopolymer microthreads. We will discuss the use of the engineering design process and its 
utility in helping designers make strategic, unbiased decisions. Broadly, the design process 
includes comprehensively defining the problem and subsequently utilizing specific quantification 
and comparison tools to direct decision-making. 
Before the actual design stage can begin, it is essential to clearly identify the project‘s 
stakeholders – the clients, the users, and the designers. Typically, the clients are the motivating 
force behind the project since they deliver an initial statement describing the ultimate goal. For 
this project, the clients, Professors George Pins and Marsha Rolle, provided a project description 
that included an initial client statement, the context and need for the project, and the expected 
deliverables. Users include research groups at WPI who are investigating the use of microthreads 
as scaffolds for the delivery of therapeutic cells to compromised tissue. The role of the designers 
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– the MQP team: Shawn Carey, Jonathan Charest, Elizabeth Ellis, and Jason Hu – is ultimately 
to translate the wants, needs, and desires of all stakeholders into a single design. 
 
3.2 Clarification of Design Goals 
Following the identification of the stakeholders, it becomes necessary for the designers to 
fully understand the goals of the project. Since the design is established by the clients, we first 
reflected on the client statement presented to our design team, which stated: 
Design and develop a co-culture system on biopolymer microthreads to identify 
cellular interactions that direct cell proliferation and differentiation for 
regenerative therapies. 
To better understand the context of the problem, we used a series of informal interviews to ask 
our clients and users questions such as: (1) how could you use such a co-culture system? (2) what 
features or attributes would you like this system to demonstrate? and (3) is there an ideal tissue-
specific application for this system?  In addition to these discussions, our design team conducted 
extensive brainstorming sessions to identify the characteristics and attributes of a co-culture 
system on microthreads. The list below includes attributes which fall into three groups: 
objectives, constraints, and functions. Objectives are the goals for the system, as determined 
through coordination among all stakeholders, constraints are the conditions of design that must 
be met for the design to succeed, and functions are the requirements that the co-culture system 
will need to allow for or perform. 
Objectives: 
Co-culture two cell types 
Identify or develop compatible conditions for more than one cell type 
Utilize biopolymer microthreads as scaffold 
Ensure microthread integrity 
Generate consistent threads 
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Generate uniform threads 
Develop consistent cell seeding methods 
Promote uniform cell seeding 
Develop means for fiber anchoring 
Develop methods for system characterization 
Promote ease of use 
Time efficient 
Modular 
Cost effective 
 
Constraints 
Materials must be commercially available 
System must be easy to maintain 
Materials must not be cytotoxic 
Materials must be sterilizable by known processes and with on-site resources 
Culture conditions must be compatible for two cell types 
Scaffold diameter must be less than 1mm 
 
Functions of the Co-Culture System 
Able to culture two cell types 
Able to seed two cell types independently in a dosage and spatially controlled manner 
Able to monitor select cell characteristics 
Able to perform immunohistochemical assays 
Able to perform viability assays 
Able to confirm effectiveness of co-culture 
Able to secure threads 
Able to control thread properties 
 
3.2.1 Objectives 
As we began to more fully understand the motivation and significance of the project, we 
were able to draft a list of pruned project objectives. From this, we identified top-level objectives 
as well as sub-objectives and created an indented objectives list. After a series of revisions to this 
list, we developed a better organized, more focused set of project objectives as shown below. 
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I. Create Effective Co-culture 
A. Maintain cell viability 
B. Uniform cell seeding 
C. Consistent cell seeding 
D. Compatible cell types 
II. Utilize Biopolymer Microthreads as Scaffolds 
A. Thread integrity 
B. Thread anchoring 
C. Uniform threads 
D. Thread stability (over time) 
E. Consistent threads (batch to batch) 
III. Develop Methods for System Characterization  
A. Non-terminal system characterization 
B. Accurate 
C. Consistent 
D. Reliable 
IV. Cost Effective 
V. User Friendly 
A. Upgradeable 
B. Ease of use 
C. Modular 
VI. Time Efficient 
 
As shown in the indented objectives list, there are six top-tier project objectives: create 
effective co-culture, utilize biopolymer microthreads, develop methods for system 
characterization, cost effective, user friendly, and time efficient. The designers established that, 
to create effective co-culture in our system, it is important to maintain cell viability, demonstrate 
consistent (batch-to-batch) and uniform cell seeding, and utilize compatible cell types.  
One of the primary requirements of the co-culture system is to utilize biopolymer 
microthreads as a scaffold for cells. To do so effectively, the design team determined that 
methods would have to be developed to ensure initial integrity and sustained stability of the 
threads, anchoring of the threads, and consistent and uniform threads.  
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Methods for system characterization serve as validation for a specific application (i.e. 
cardiac, orthopedic, etc.) and more specifically, allow the user to assess whether the system 
functions as desired in terms of cell survival, migration, and function. These methods should be 
accurate (the characterization observation corresponds with what is actually happening in the co-
culture system), consistent (several characterization analyses on the same sample generate the 
same results), reliable, and non-terminal. Finally, the system must be user friendly; that is, it will 
be upgradeable (an individual component of the system could be improved), easy to use, and 
modular (can accommodate several different cell types). 
 
3.2.2 Quantitative Analysis of Objectives 
Since the design process relies on a strategic approach to decision making, a weighted 
objectives tree must be formulated from the indented objectives list to prioritize the goals of the 
project. A tool that is commonly used to rank items relative to one another is a pairwise 
comparison chart. Objectives at the same level, such as the major, top-tier objectives or all of the 
sub-objectives branching off of a major objective, are methodically compared. When using a 
pairwise comparison chart to compare two items, the more important of the two receives a score 
of 1 while the less important receives a 0. If the compared items are equally important to the 
design, each is given a score of 0.5. After the scores for each objective were summed, they were 
normalized by adding one, which is a standard method to generate only nonzero values [50]. 
These values can then be compared as weights, which would be impossible with a score of zero. 
For this project, the following weights were assigned to the stakeholders for these comparisons: 
client George Pins (1/3), client Marsha Rolle (1/3), design team (1/3). The results of the top-tier 
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pairwise comparison charts are shown in Table 1 with the design team‘s score in the left columns 
and the sum of the clients‘ scores in the right columns. 
Table 1: Pairwise Comparison Chart of First-Tier Objectives. 
Project Objectives I II III IV V VI Score 
Normalized 
Score 
Weight 
I. Create Effective Co-Culture   0.5 1.0 1.0 2.0 1.0 2.0 1.0 2.0 1.0 2.0 13.5 14.5 0.28 
II. Utilize Biopolymer Microthreads 0.5 1.0   1.0 2.0 1.0 2.0 1.0 2.0 1.0 2.0 13.5 14.5 0.28 
III. Methods for System Characterization 0.0 0.0 0.0 0.0   1.0 1.5 1.0 2.0 1.0 2.0 8.5 9.5 0.19 
IV. Cost Effective 0.0 0.0 0.0 0.0 0.0 0.5   1.0 1.0 0.0 1.5 4.0 5.0 0.10 
V. User Friendly 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0   0.0 0.5 1.5 2.5 0.05 
VI. Time Efficient 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 1.0 1.5   4.0 5.0 0.10 
 
Comparison of the six primary objectives demonstrates that although all of the project 
objectives are essential, some are clearly more important to consider in the design process. The 
stakeholders identified the two major objectives Create Effective Co-Culture and Utilize 
Biopolymer Microthreads as Scaffolds as the most important, followed by Include Methods for 
System Characterization, Cost Effective, Time Efficient, and User Friendly. The following tables 
compare the sub-objectives within each of the major objectives. 
Table 2: Pairwise Comparison Chart of Sub-Objectives I. 
I. Create Effective Co-Culture A B C D Score 
Normalized 
Score 
Weight 
A. Maintain Cell Viability   1.0 2.0 1.0 2.0 1.0 1.0 8.0 9.0 0.41 
B. Uniform Cell Seeding 0.0 0.0   0.0 1.5 0.0 0.5 2.0 3.0 0.14 
C. Consistent Cell Seeding 0.0 0.0 1.0 0.5   0.0 0.5 2.0 3.0 0.14 
D. Compatible Cell Types 0.0 1.0 1.0 1.5 1.0 1.5   6.0 7.0 0.32 
 
Within the major objective of Create Effective Co-Culture, the designers and clients 
established that Maintaining Cell Viability was the highest priority in this tier by awarding it the 
highest weighting. This sub-objective was followed by the use of Compatible Cell Types, and 
demonstrating Uniform and Consistent Cell Seeding. 
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Table 3: Pairwise Comparison Chart of Sub-Objectives II. 
II. Utilize Biopolymer Microthreads A B C D E Score 
Normalized 
Score 
Weight 
A. Thread Integrity   1.0 2.0 1.0 1.5 0.5 2.0 1.0 0.5 9.5 10.5 0.32 
B. Thread Anchoring 0.0 0.0   1.0 1.0 1.0 0.5 1.0 0.0 4.5 5.5 0.17 
C. Uniform Threads 0.0 0.5 0.0 1.0   0.0 1.0 0.0 0.0 2.5 3.5 0.11 
D. Thread Stability (over time) 0.5 0.0 0.0 1.5 1.0 1.0   0.5 1.0 5.5 6.5 0.20 
E. Consistent Threads (batch to batch) 0.0 1.5 0.0 0.0 1.0 2.0 0.5 1.0   6.0 7.0 0.21 
 
The stakeholders determined that, with respect to the biopolymer microthreads, in order from 
most to least important, the system must maintain Thread Integrity, produce Consistent and 
Stable Threads, enable Thread Anchoring, and generate Uniform Threads. 
Table 4: Pairwise Comparison Chart of Sub-Objectives III. 
III. Include Methods for System 
Characterization 
A B C D Score 
Normalized 
Score 
Weight 
A. Non-terminal System Characterization   0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.05 
B. Accurate 1.0 2.0   1.0 0.5 1.0 1.0 6.5 7.5 0.34 
C. Consistent 1.0 2.0 0.0 1.5   0.0 2.0 6.5 7.5 0.34 
D. Reliable 1.0 2.0 0.0 1.0 1.0 0.0   5.0 6.0 0.27 
 
The most important sub-objectives under the Include Methods for System Characterization 
tier were that the characterization system be Accurate and Consistent. Furthermore, the system 
should be Reliable in that it delivers definitive results. Non-terminal System Characterization 
would be ideal, but this sub-objective is a relatively low priority because the goal of this project 
is to develop a proof-of-concept system. 
Table 5: Pairwise Comparison Chart of Sub-Objectives V. 
V. User Friendly A B C Score 
Normalized 
Score 
Weight 
A. Upgradeable   0.0 0.0 0.0 0.5 0.5 1.5 0.13 
B. Ease of Use 1.0 2.0   1.0 2.0 6.0 7.0 0.58 
C. Modular 1.0 1.5 0.0 0.0   2.5 3.5 0.29 
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Finally, under the top-tier objective of User Friendly, Ease of Use was the highest weighted 
characteristic. The second-ranked sub-objective in this category was Modular (i.e. using the 
microthread scaffold as a platform for any number of different cell types and applications); 
development of an Upgradeable (scalable) system ranked least important of the three sub-
objectives. 
After using the pairwise comparison charts to quantify and prioritize the stakeholders‘ 
interests in developing this novel co-culture system, the design team created a weighted 
objectives tree to summarize our results (see Figure 5). The first number in each box represents 
that objective‘s relative weighting within its branch; the boldface value defines where each sub-
objective ranks with respect to all other objectives at the same level (i.e. major objectives, sub-
objectives). 
 
 
 
Figure 5: Weighted Objectives Tree. 
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Figure 6: Summary of Weighted Objectives Tree. 
 
3.2.2 Development of Revised Client Statement 
Based on the objectives analysis and further research, the original client statement ―Design 
and develop a co-culture system on biopolymer microthreads to identify cellular interactions that 
direct cell proliferation and differentiation for regenerative therapies.‖ was revised. 
The revised client statement was: 
Design and develop a cellular co-culture system on biopolymer 
microthreads that will facilitate guided angiogenesis. 
The most important objective of this project was to develop a co-culture system for cell 
delivery using biopolymer microthreads as scaffolds. Co-culture of the chosen cell types must 
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demonstrate significant potential for promoting and directing angiogenesis relative to a single 
cell system. The design of this co-culture system should ensure thread integrity and cell viability 
for at least three days in culture. The system should be easy to use, time efficient, cost effective, 
and modular. The design should minimize batch-to-batch variability. A set of comprehensive 
characterization procedures should be developed to monitor the viability, morphology, 
migration, and cell-cell signaling for the co-culture system. 
 
3.3 Project Approach 
The design team developed a two-step approach to facilitate the independent seeding of two 
cell types. The first cell type would be embedded within the collagen microthread scaffold (I in 
Figure 7). After a period of incubation, the second cell type would be seeded on the surface of 
the cell-populated collagen microthread scaffold (II in Figure 7). 
 
Figure 7: Novel Approach to Co-Culture on a Collagen Microthread Scaffold. This approach allows for independent seeding 
of two cell types. 
 
Because of the complexity of the proposed system and the anticipated challenges in 
implementing this approach, we broke it into three Specific Aims.  These broad goals represent 
benchmarks that we determined must be met in order to achieve the design objectives. 
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Specific Aim 1: Provide a 3-D culture environment for therapeutic cell types by embedding 
one of the cell types in a collagen microthread. 
There are two motivations for utilizing microthread scaffolds in this way. Ongoing research 
has shown that cues from the extracellular matrix in 3-D microenvironments can significantly 
affect biochemical signaling pathways between and within cells. Providing a culture 
microenvironment that more closely resembles the native ECM will lead to more natural cellular 
activity and ultimately a more effective culture system. Embedding the first cell type within the 
thread will also allow for independent seeding of the second cell type as well as dose, spatial, 
and temporal control over cell seeding. 
 
Specific Aim 2: Seed second cell type on the surface of a collagen microthread. The 
objective of this aim is to develop a seeding technique that has the potential to more 
effectively seed a chosen cell type on the surface of the microthread. 
The effectiveness of traditional methods of seeding cells on microthreads such as droplet 
seeding is limited because of insufficient cell attachment (as seen in Figure 8). Further, these 
methods give the user little control over cell location. Therefore, new methods must be 
developed to improve the seeding efficiency and control. 
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Figure 8: Inefficiency of Traditional Seeding Methods on a Microthread Scaffold. 
 
Specific Aim 3: Demonstrate the ability to maintain a long-term cellular co-culture system. 
After methods have been developed to I) effectively embed one cell type within a collagen 
microthread and II) effectively seed the second type on the surface of the thread, it will be 
critical to combine the two methods to evaluate the feasibility of establishing a co-culture 
system. As discussed in the Literature Review chapter, co-culture systems have shown many 
advantages over single culture systems. However, such systems have never been studied on 
biopolymer microthreads. Validating the feasibility of such therapeutic co-culture systems on a 
microthread would promote future development toward use as delivery vehicles for therapeutic 
cells. 
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4. Alternative Designs 
4.1 Conceptual Designs 
4.1.1 Development of Design Alternatives for Fabrication 
To facilitate the development of alternative designs, the team held a brainstorming session 
for all stakeholders in this project. Nineteen fabrication techniques for the co-culture system 
were brainstormed and, because many of the proposed ideas shared common mechanisms for the 
fabrication of a co-culture system, eight design alternatives were identified. Each of these 
alternatives was investigated and an illustration, description, and pros and cons are discussed 
below. 
Extrusion: 
Designs under this category utilize a collagen thread extrusion method adapted from the Pins 
Lab [51]. Collagen and cell suspensions are extruded through small diameter tubing into a 
temperature and pH-controlled buffer solution to promote collagen polymerization (Figure 9). 
 
Figure 9: Cartoon Illustrating Basic Extrusion Procedure. 
 
 
 
 
 
40 
Pros: 
 Allows for cell embedding 
 Control over thread dimensions 
 Allows for media diffusion 
 Well-characterized technique 
 
Cons: 
 Potential for premature polymerization in 
extrusion tube 
 Potential adverse cellular response to 
shear stresses during extrusion 
 Incomplete mixing/uneven cell 
distribution 
 
Molding: 
Channels with defined dimensions are created on a non-adhesive and biocompatible material 
such as Polydimethylsiloxane (PDMS) or agarose. Collagen and cell suspensions are mixed and 
injected into these channels; the device is submerged in a temperature and pH-controlled buffer 
solution for collagen polymerization (Figure 10). 
 
Figure 10: Cartoon Illustrating Basic Molding Procedure. 
 
Pros: 
 Allows for cell embedding 
 Control over thread dimensions 
 Individual channels prevent tangling 
during production 
 Could allow for seeding of two cell types 
 
Cons: 
 Restricted media diffusion due to mold 
 Does not allow for independent seeding 
of two cell types 
 Not a true ―thread‖ morphology 
 Lack of thread integrity 
 Difficult to harvest threads from  mold 
 Settling of cells in collagen resulting in 
uneven distribution 
 Requires machining of mold 
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Parfait Molding: 
Similar to molding described above; collagen is mixed independently with suspensions of 
cell types A and B. The resulting solutions are injected alternately into channels with defined 
dimensions to create a ―parfait‖ consisting of both cell types embedded. This approach could be 
used with a horizontal mold as shown below or in a vertical cylindrical mold (Figure 11). 
 
 
Figure 11: Cartoon Illustrating Parfait Molding Procedure. 
 
Pros: 
 Allows for cell embedding 
 May allow for localization of both cell 
types and somewhat independent seeding 
 Control over thread dimensions 
 Individual channels prevent tangling 
during production 
Cons: 
 Restricted media perfusion due to mold 
 Not a true ―thread‖ structure 
 Lack of thread integrity, especially due to 
interfacial boundaries 
 Difficult to harvest threads from mold 
 Settling of cells in collagen resulting in 
uneven distribution 
 Requires machining of mold 
 
Extrusion/Microfluidic Mixing: 
Essentially, this procedure provides more effective mixing prior to either extrusion or 
molding. Small microfluidic channels are created on Teflon or another biomaterial. The collagen 
solution and cell suspensions are pumped into the channel, mixed thoroughly, and exit the 
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mixing channel homogenously mixed (Figure 12); the resulting solution can be molded or 
extruded. 
 
 
Figure 12: Cartoon Illustrating Microfluidic Mixing Procedure. 
 
Pros: 
 Allows for cell embedding 
 Thorough mixing/even cell distribution 
 Homogenous mixing minimizes variation 
in mechanical integrity of the thread 
 Used to pre-mix solutions for extrusion 
or molding 
Cons: 
 Does not allow for independent seeding 
of two cell types 
 Potential adverse cellular reaction to 
turbulent mixing 
 Additional step and equipment 
 Potential for premature polymerization 
 Requires machining of device 
 
Rolling: 
A thin collagen gel or film is seeded with cells and incubated to allow for adequate cell 
attachment. The number, density, and location of one or more cell types can be controlled. The 
cell-seeded gel is removed from the dish and rolled upon itself to create a cylindrical construct 
(Figure 13). 
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Figure 13: Cartoon Illustrating Rolling Procedure. 
 
Pros: 
 Allows for cell embedding 
 Ability to deliver more than one cell type 
 Ability to control number, density, and 
location of cells 
 Maximize seeding efficiency 
Cons: 
 Not a true microthread 
 Much larger dimensions than 
microthreads 
 Requires handling and manipulation 
during production 
 
Magnetic Seeding: 
Iron atoms are incorporated within the microthread through co-extrusion as well as loaded 
into the cells that are to be seeded on the thread. The thread and cells are magnetized so that the 
cells are attracted to the thread when exposed to a magnetic field (Figure 14). 
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Figure 14: Cartoon Illustrating Magnetic Seeding Procedure. 
 
Pros: 
 Utilizes established extrusion techniques 
 Control over thread dimensions 
 Potential for cell tracking using iron-
loading cells 
 
Cons: 
 Surface seeding only 
 Does not involve second cell type, 
secondary seeding required 
 No spatially-selective seeding 
 Potential adverse cellular reaction to iron 
Spatial Chemical Seeding: 
Surface treatments such as ionic charge and/or polymeric coatings are applied in a controlled 
manner to the microthreads to selectively control cell adhesion of one or more cell types. Surface 
treatments used to block attachment of cell type A are subsequently removed to allow cell type B 
to attach, resulting in a controlled distribution and number of both cell types. The advantage of 
this method is that it is possible to independently seed two cell types (Figure 15). 
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Figure 15: Cartoon Illustrating Spatial Chemical Seeding Procedure. 
 
Pros: 
 Utilizes established extrusion techniques 
 Control over thread dimensions 
 Control over seeding concentration, 
distribution 
 Ability to seed two cell types 
independently 
Cons: 
 Surface seeding only 
 Inefficient seeding as a result of selective 
seeding 
 Potential adverse cellular reaction to 
chemical manipulation 
 Potential adverse biomaterial reaction to 
chemical manipulation 
 
Centrifugation: 
Biopolymer microthreads are secured on the surface of a non-adhesive culture plate. Cell 
suspensions are added to the plate before centrifugation. The centripetal force will drive the cells 
to adhere to the microthreads. This strategy could be coupled with one of the selective seeding 
techniques described above (Figure 16). 
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Figure 16: Cartoon Illustrating Centrifugation Seeding Procedure. 
 
Pros: 
 Utilizes traditional extrusion techniques 
 Maximize seeding efficiency 
Cons: 
 Surface seeding only 
 Potential thread deformation and damage 
due to high forces 
 Potential damage to cells due to high 
forces 
 
4.1.2 Strategic Analysis of Design Alternatives 
After the generation of design alternatives, it was necessary to determine which design best 
conformed to the project objectives while satisfying the project constraints. Only those design 
alternatives that fulfilled all of the constraints were to be included in the strategic decision-
making process. It was concluded that designs utilizing the rolling technique would not be able 
to produce true ―microthreads‖ and there may be some issues with thread integrity and long-term 
stability if the construct were to unroll. Furthermore, production of cell-seeded scaffolds by this 
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method would require extensive handling and manipulation. Therefore, this technique could not 
be used as it failed to meet all of the constraints. 
A Best of Class chart (Figure 17) was used to compare the relative ability of each of the 
remaining seven design alternatives to satisfy the weighted objectives. The design alternatives 
were ranked from 1-7 as to how well they address each project objective. The design that best 
fulfilled any given objective was awarded a score of 1. If two designs achieved a given objective 
equally well and were both determined to be the best alternative for that objective, the resulting 
score for both alternatives was the average of 1 and 2 (1.5). This technique is commonly used in 
Best of Class charts and guarantees proportional comparison. Weighted scores were calculated 
by multiplying the Best of Class chart scores by the objectives‘ weights that the design team had 
previously assigned. The alternatives with the lowest total weighted scores were deemed to be 
the best choices for fabrication techniques. Objectives that were not relevant to the choice of 
fabrication technique were omitted from this analysis. 
 
Figure 17: Best of Class Chart. Chart compares various fabrication techniques to weighted objectives. Score-
dependent coloring is used to visualize rankings. Green scores indicate good anticipated fulfillment of the objective, 
while red scores indicate poor anticipated fulfillment. 
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The Best of Class chart indicated that the best fabrication methods given our constraints, 
objectives, and desired functions would be molding and extrusion. These processes would both 
allow for cell embedding, which would facilitate independent cell seeding when used in 
conjunction with a surface seeding technique. In particular, we anticipated that these methods 
would create uniform and mechanically stable threads with a high degree of cell viability. 
Through the design process, it was determined that the ability to create an actual ―microthread‖ 
was especially important. The benefits of microthreads as scaffolds in cell-based applications 
have previously been identified in the Background section, and it was determined that several of 
the key features of biopolymer microthreads, including fibrillar alignment, rapid polymerization, 
and thread integrity, are imparted through the extrusion process (as described by Pins, et al. 
[51]). 
 
4.2 Selection Process for Co-culture Cell Types 
In the brainstorming session, possible cell types to use in this project were discussed. The 
following is a list of possible cell types: 
Human dermal fibroblasts (HDFs) 
Human mesenchymal stem cells (hMSCs) 
Smooth muscle cells (SMCs) 
Keratinocytes 
Endothelial cells 
Skeletal muscle cells 
3T3-J2 cells 
Cardiac myocytes 
Induced pluripotent cells (IPCs) 
Because one of the goals of the project was to utilize a co-culture system, it was necessary to 
determine the feasibility of using each of the cell types that was proposed during the 
brainstorming session. By constructing a matrix that specified all of the possible combinations of 
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cells, we organized the proposed co-culture systems in terms of co-culture outcomes. A thorough 
literature review revealed that only eleven of the combinations had been previously studied. 
Table 6 shows the eleven combinations with their studied measurable outcome.  
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Table 6: Possible Co-Culture Combinations. 
Co-Culture Combination Measureable Outcome 
SMCs & 
hMSCs 
↑ (increased) Expression of smooth muscle calponin & smooth muscle 
α-actin 
[52] 
Keratinocytes & 
Dermal fibroblasts 
↑ Expression of IL, KGF, & TGF 
↑ Contractility in myofibroblasts 
[53, 54] 
Skeletal myoblasts & 
hMSCs 
↑ Proliferation rates of both cell types 
[55] 
Skeletal myoblasts & 
SMCs 
↑ [VEGF] causing myoblasts to turn into SMCs 
[56] 
Endothelial cells & 
Dermal fibroblasts 
↑ Angiogenesis in vitro 
[46] 
Endothelial cells & 
hMSCs 
Mimics development of vascularization 
[57] 
Endothelial cells & 
SMCs 
Activation of SMC protein kinase Akt 
[58] 
3T3-J2s & 
Keratinocytes 
↑ Keratinocyte production of FN, LN, and Col-IV 
[59] 
Cardiac myocytes & 
hMSCs 
↑ Expression of cardiac connexins in hMSCs and gap junction 
formation and induced hMSC expression of α-actin 
[52, 60] 
Cardiac myocytes & 
Skeletal myoblasts 
Induced cell fusion and morphological changes 
[61] 
Cardiac myocytes & 
Endothelial cells 
Induced endothelial cell expression of sarcomeric MHC, β-
galactosidase, cardiac troponin-I, and active gap junctions 
[62] 
 
Of these co-culture systems, the team chose to utilize combination of endothelial cells and 
dermal fibroblasts. This particular combination was chosen based on its well-characterized 
ability to emulate the process of angiogenesis in vitro. Further, there remains a need for a tissue 
engineered deliverable construct capable of promoting angiogenesis in vivo. The recapitulation 
of vascularization through induced angiogenesis evolved into a significant goal of the project. It 
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was determined that the endothelial cells would be seeded on the surface of the microthread 
based on previous studies done by Velazquez et al. [6] that indicate the preference of endothelial 
cells to migrate into a fibroblast-populated collagen gel. Furthermore, the team chose to 
incorporate the fibroblasts within the thread because they were more likely to survive the 
potentially harsh microenvironments of the extrusion process. By embedding the easily cultured 
fibroblasts inside a collagen microthread and subsequently seeding endothelial cells onto the 
surface, we hope to create a pro-angiogenic co-culture system on the microthread. The use of 
fibroblasts and endothelial cells was considered to be particularly advantageous because of their 
broad and well-characterized use in angiogenesis models and tissue engineering applications. 
 
4.3 Preliminary Co-culture System Design 
Taking into account the revised client statement, the results of the strategic selection methods 
and the resources available to the design team, a preliminary design was chosen. The design 
utilized extrusion of human dermal fibroblasts (HDFs) within the collagen threads and seeding of 
human umbilical vascular endothelial cells (HUVECs) onto the surface of the extruded threads. 
This approach is shown in Figure 18 and allowed for independent seeding of the two cell types 
and user control over cell-specific incubation times. The cell types were chosen because their 
interactions best promote angiogenesis in surrounding tissue. Furthermore, previous research has 
shown that endothelial cells seeded on a collagen gel will migrate into the gel and form tubules 
in response to gradients of factors secreted by the fibroblasts as well as cell-cell contact. The 
proposed system will serve as a platform for the further characterization of the cell-cell and cell-
matrix interactions that are critical for therapeutic angiogenesis and may ultimately serve as a 
cell delivery vehicle that promotes guided angiogenesis in vivo. 
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Figure 18: General Approach Schematic to Seed Fibroblasts and Endothelial Cells. This approach allows for independent 
seeding of the two cell types on a collagen microthread 
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5. Design Verification 
The design process was used to determine that the novel co-culture system would consist of 
an extruded collagen microthread containing embedded human dermal fibroblasts and surface-
seeded with human umbilical vein endothelial cells. Initial pilot studies were conducted to 
develop and validate effective methods for extruding the HDF-populated thread scaffolds under 
sterile conditions, surface seeding of HUVECs, visualizing cells both within and on the surface 
of the threads, and distinguishing between the two cell types during characterization. The 
complete protocols for all studies are in Appendix C. Construction of the co-culture system was 
then accomplished by combining the developed methods for independent seeding of the two cell 
types in and on the collagen threads (Figure 18). 
 
5.1 HDF-Collagen Co-Extrusion Preliminary Studies 
5.1.1 Pre-loading of HDFs with MitoTracker 
Human dermal fibroblasts were pre-loaded with MitoTracker to facilitate non-terminal 
visualization. Following the manufacture protocol, HDFs were incubated in a 0.05% (V:V) 
MitoTracker/DMEM solution for 15 minutes. After rinsing twice with standard DMEM, cells 
were incubated in DMEM at 37 °C for at least 2 hours before use. A phase contrast/fluorescence 
overlaid image of HDFs with the green fluorescent MitoTracker can be seen in Figure 19. 
Minimal HDF autofluorescence was observed relative to the MitoTracker signal. 
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Figure 19: Pre-Loading of HDFs with MitoTracker. Phase contrast/fluorescence overlay image of MitoTracker Green-loaded 
human dermal fibroblasts (left). Unloaded fibroblasts showed no autofluorescence in green channel (right). Scale bar = 100 μm. 
 
5.1.2 Preliminary HDF-Collagen Co-Extrusion 
To develop an extrusion protocol for embedding HDFs, a preliminary experiment was 
conducted under non-sterile, 4°C (cold room) conditions. The method used was adapted from a 
cell-seeded collagen gel protocol. Briefly, acid-soluble type I collagen was placed in a 1 mL 
syringe and a combination of 5X DMEM and human dermal fibroblast cell suspension (80,000 
cells/mL) in standard culture media was placed in another 1 mL syringe. The contents of the 
syringes were extruded through a mixing connector tip and polyethylene tube with inner 
diameter of 0.86 mm into a temperature-controlled 37°C bath of DMEM culture media. After 15 
minutes, the short lengths of extruded collagen microthread (2-3 cm) were fixed and stained with 
Hoechst for visual analysis. A representative bright field/fluorescence overlaid image is shown in 
Figure 20. This experiment demonstrated the ability to co-extrude collagen and HDFs as well as 
the utility of MitoTracker in short-term non-terminal visual characterization. However, there 
were limitations to this pilot study and several questions derived from the results. First, only 
short lengths of threads were produced and they were difficult to handle with forceps. Also, 
while MitoTracker-positive cells (indicated by co-localization of Hoechst and MitoTracker) were 
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identified within the boundaries of the threads as shown by white arrow heads, it was not clear 
whether these cells were actually within the thread. Furthermore, it was impossible to tell 
whether the cells were alive after exposure to the co-extrudants at this time point and using these 
methods. Finally, this pilot study was conducted under non-sterile conditions in a 4°C cold room 
to better control polymerization of the collagen. Longer-term culture (3-5 days) requires stable 
threads, effective embedding of HDFs, high cell viability, and sterile fabrication conditions. 
Additionally, it is also important to note that very little auto-fluorescence was exhibited by the 
collagen threads under the green filter. 
 
 
Figure 20: Preliminary HDF-Collagen Extrusion. Bright field/fluorescence overlay image of a thread containing MitoTracker-
loaded HDFs (green) and stained with Hoechst (nuclei; blue); HDF presence was determined by the co-localization of 
MitoTracker-loaded cells with a nucleus. Smaller blue particles not associated with a MitoTracker-positive HDF were identified 
as the result of non-specific binding of Hoechst stain to impurities in the collagen. HDFs are indicated by white arrow heads and 
thread boundaries are highlighted by white lines. Scale bar = 100 μm. 
 
 
5.1.3 Co-Extrusion Components Cytotoxicity Study 
To evaluate the potential cytotoxicity of the components of the co-extrusion system, human 
dermal fibroblasts were exposed to the components individually for 10 minutes. MitoTracker-
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positive HDFs in standard culture media exhibited no change in morphology when exposed to 
5X DMEM and 10 mg/mL collagen (Figure 21). It was determined that short-term exposure to 
these components was not harmful to HDFs and therefore, the extrusion components were 
considered satisfactory. 
 
Figure 21: Co-Extrusion Components Cytotoxicity Study. Fluorescence images of MitoTracker-positive human dermal 
fibroblasts before (left column) and after (right column) 10 minutes of exposure to the co-extrusion components. No changes in 
morphology were observed. 
 
5.1.4 Validation of Co-Extrusion Preliminary Study 
The co-extrusion pilot study was repeated as previously described at room temperature rather 
than 4°C to better simulate the environment of the sterile tissue culture hood. Working at 
approximately 25°C with room temperature extrudants failed to produce intact threads, and other 
methods of fabrication were considered. 
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5.1.5 Acellular Co-Extrusion into FFB 
Standard collagen microthread extrusion utilizes an optimized buffer to facilitate self-
assembly. Therefore, a modification was made to the co-extrusion pilot study protocol where 
threads were extruded into 37°C fiber formation buffer (FFB; pH 7.42, 135 mM NaCl, 30 mM 
TrizmaBase, and 5 mM NaPO4 dibasic; Sigma, St. Louis, MO) to enhance gelling of the 
collagen and promote thread integrity (Figure 22A). Threads were incubated in FFB for either 30 
(Figure 22C) or 60 (Figure 22D) minutes. After just 30 minutes in FFB, threads demonstrated 
suitable thread integrity by supporting their own weight (Figure 22B). Further, threads from the 
two groups were visually indistinguishable after 6 hr, suggesting 30 minutes in FFB is sufficient 
for promoting collagen gelling. The results of this study are summarized in Table 7. 
 
 
Figure 22: Acellular Co-Extrusion into 37°C FFB. A: Extrusion set-up; threads were extruded into 37 °C fiber formation 
buffer (FFB) and incubated for 30 or 60 minutes. B: Threads incubated in FFB for 30 minutes possess mechanical stability and 
ability to support their own weight. C &D: Threads extruded into FFB and incubated for 30 minutes (C) or 60 minutes (D) 
demonstrate no discernible differences. Threads are indicated by white arrow heads. 
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Table 7: Methods/Results of Acellular Co-Extrusion into 37°C FFB Study. Threads incubated for 30 (FFB30) and 60 
(FFB60) minutes were intact, yet visually indistinguishable after 6 hours in culture. 
 
Threads produced by this method had an accordion- or corkscrew-like structure. It was 
hypothesized that this was the result of non-homogeneous polymerization occurring during co-
extrusion. With a constant flow rate, changes in the diameter of the container through which a 
fluid is flowing (syringe  needle  PE tubing) cause changes in the velocity of that fluid, 
which may have caused a ―pile-up‖ effect within the tubing. Polymerization of the collagen also 
affected the viscosity, which further changes the flow properties of the gelling collagen solution. 
Repeating this experiment failed to produce threads; it was determined that this was due to 
the use of room temperature collagen (instead of 4°C) and incomplete mixing of the extrudants. 
While incorporating FFB into the protocol was considered an improvement over previous 
methods, new techniques were to be evaluated for extrusion and fabrication of the threads. New 
methods will be discussed further in the following sections and will involve thorough mixing of 
the extrudants prior to being extruded to allow for more uniform flow and the fabrication of more 
uniform and cylindrical threads. 
 
5.1.6 FFB Cytotoxicity Study 
As was previously mentioned, the use of FFB as a bath to extrude threads into was thought to 
be an improvement over the use of culture media. To evaluate to potentially cytotoxic effects of 
Time  0 min 30 min 60 min 6 hr 
FFB30 
(30 min in 
FFB) 
extruded 
transfer to media 
- stable threads 
- stable threads 
- supports own 
weight 
- some loss of integrity 
- ―frills‖ around thread 
- film developing on 
surface of media 
-  able to be handled 
-  supports own weight 
FFB60 
(60 min in 
FFB) 
extruded --- 
transfer to media 
- stable threads 
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exposing human dermal fibroblasts to fiber formation buffer, MitoTracker-positive HDF cultures 
were incubated with PBS, FFB, and EtOH for 60 minutes. Figure 23 shows phase 
contrast/fluorescence images taken at 10. 
 
 
Figure 23: Fiber Formation Buffer (FFB) Cytotoxicity. Phase contrast/fluorescence overlay of MitoTracker Green-positive 
HDFs on tissue culture plastic exposed to FFB, PBS, or EtOH for 60 minutes (A, B, C, respectively). Samples were stained with 
‗Dead‘ component of Live/Dead stain (ethidium homodimer, EthD-1, red) following incubation. Cells incubated in FFB and PBS 
exhibited no discernable difference in viability, whereas all cells exposed to EtOH were dead (with no MitoTracker signal 
present). Scale bar = 100 μm. 
 
5.1.7 Acellular and HDF-Collagen Cold-Mix Extrusion 
One of the most significant objectives of the pilot studies was to develop a protocol to 
fabricate stable lengths of HDF-containing collagen microthreads in a reproducible manner. 
Previous attempts to repeat co-extrusion experiments into both DMEM and FFB failed to yield 
threads, likely due to insufficient and/or uncontrolled mixing of the extrudants and improper 
temperature control. To overcome this difficulty, the extrudants (collagen, 5X DMEM, and cell 
suspension) were mixed thoroughly by pipette before being drawn into a syringe for extrusion. 
Additionally, the collagen and 5X DMEM were kept on ice until just before use, optimizing the 
user‘s control over gelling conditions. HDFs were pre-loaded with MitoTracker as previously 
described. Briefly, the three solutions were mixed carefully as to not create bubbles at a 4:3:1 
(collagen : DMEM + 180,000 HDFs/mL : 5X DMEM) ratio. The mixture was drawn into a 
syringe and extruded at a rate of 0.25 mL/min through 0.86 mm (ID) polyethylene tubing into 
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sterile 37°C FFB. After 30 minutes of incubation, the FFB was removed and replaced with 
standard culture media (DMEM). This study was conducted under sterile conditions in a tissue 
culture hood. This procedure is shown schematically in Figure 24 and a representative 
microthread in culture media is shown in Figure 25: HDF-Seeded Collagen Microthread Created 
by Cold-Mix Extrusion.. 
 
Figure 24: Cartoon Schematic of HDF-Collagen Cold-Mix Extrusion Method. 
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Figure 25: HDF-Seeded Collagen Microthread Created by Cold-Mix Extrusion. 
 
Four hours after extrusion, HDF-populated collagen microthreads were removed from culture 
media and visually inspected using phase contrast and fluorescence microscopy. MitoTracker-
loaded HDFs were distributed throughout the thickness of the thread and were within the 
boundaries of the thread (Figure 26). 
 
 
Figure 26: HDF-Seeded Collagen Microthreads 4h after Extrusion. Phase contrast/fluorescence overlay. Prior to cell 
spreading, HDFs appear as green balls. Scale bar = 100 m. 
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While analysis 4h after extrusion demonstrated effective embedding of HDFs within collagen 
microthreads, this method did not confirm cell viability. To show that cell viability was 
maintained through the extrusion process, HDF-seeded collagen microthreads were fixed 4h and 
24h after extrusion and stained with phalloidin (actin; green) and Hoechst (nuclei; blue) to 
visualize changes in cell morphology. As Figure 27 shows, 24h after extrusion, HDFs exhibited 
an increasingly spread morphology. 
 
 
Figure 27: HDF Morphology 4h and 24h after Extrusion. Fluorescent images of HDFs in collagen threads 4h (left) and 24h 
(right) after the cold-mix extrusion process. White arrows indicate changes in HDF morphology. Samples were stained with 
phalloidin (actin; green) and Hoechst (nuclei; blue). 
 
5.2 HUVEC Surface Seeding Preliminary Studies 
Once an effective method of embedding HDFs within the thread was established, it was 
necessary to pursue a method for seeding the HUVECs on the thread surface. Two specific 
challenges needed to be addressed to accomplish this. First, the HUVECs needed to be visually 
distinguishable by microscopy from the HDFs both in culture and after fixation. Second, an 
efficient and effective method of seeding needed to be developed. 
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5.2.1 Pre-Loading of HUVECs with DiI-ac-LDL 
One technique that would allow for both terminal and non-terminal imaging of the HUVECs 
was to pre-load the cells with an endothelial cell-specific fluorescent marker. DiI (a fluorescent 
molecule) conjugated to acetylated LDL (low-density lipoprotein) is one such marker. When 
incubated with the marker, endothelial cells will endocytose the molecule, localizing it within the 
cytoplasm and making the cells easily identifiable. HUVECs were incubated with DiI-Ac-LDL 
(BT-902, Biomedical Technologies Inc., Stoughton, MA) at 10 μg/mL in EGM for 4 hours, 
rinsed with PBS, and left to rest in EC culture media for at least 4 hours before use. Pre-loaded 
HUVECs were imaged at 10 and are shown in Figure 28. 
 
Figure 28: DiI-ac-LDL Labeled HUVECs. Phase contrast/fluorescence overlaid image of human umbilical vein endothelial 
cells following DiI-ac-LD uptake (left panel). Unlabeled human umbilical vein endothelial cells exhibit no fluorescence in the 
orange channel (right panel). Scale bar = 100m. 
 
5.2.2 Fabrication of HUVEC Surface Seeding Device 
 To effectively seed HUVECs on the surface of the threads, a concept similar to the 
molding design alternative was utilized. The initial idea was to place the thread on a culture plate 
and incubate it in a suspension of cells for a short period of time. While this would accomplish 
the task of getting cells onto the surface of the thread, it has been shown to be very inefficient 100 µm 
 
64 
and yields a small number of cells attached. An improved method of seeding cells on the thread 
surface was developed using a modified version of a device created by Darshan Parekh, a 
graduate student in the Rolle Lab at WPI. This device would contain channels that would prevent 
movement of the thread during the surface seeding process and would facilitate more effective 
surface seeding by providing a constrained geometry and volume. A custom-built mold was 
made from polycarbonate using CNC machining. This mold acted as a negative template for the 
molding of PDMS seeding device (Figure 29; Figure 30). Polydimethylsiloxane (PDMS; Sylgard 
184 silicone elastomer kit, Dow Corning, Midland, MI) was mixed with a curing agent at a 10:1 
ratio (w/w). The mixture was then poured onto the polycarbonate mold and degassed under 
vacuum for 30 minutes before being cured at 60°C for 3 hours. The final PDMS seeding device 
is shown in the bottom-right panel of Figure 30. 
 
Figure 29: CAD Drawing of Custom PDMS Mold. Drawing includes dimensions. 
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Figure 30: Schematic and Images of a HUVEC Surface Seeding Device. 
 
5.2.2 HUVEC Surface Seeding 
Briefly, acellular threads (produced by cold-mix extrusion) were removed from culture 
media, rinsed with PBS, and placed in the custom-built surface seeding device. As was 
previously discussed, this device provides a constrained volume and geometry that facilitates cell 
contact and adhesion to the curved surface of the collagen microthreads. One hundred-fifty 
microliters of DiI-Ac-LDL pre-loaded HUVEC cell suspension (66,000 cells/mL) were pipetted 
onto the surface of each microthread as shown in Figure 31. The cells were allowed to adhere for 
4 hours. After the incubation period, the threads were rinsed with PBS and inspected using 
fluorescence microscopy (Figure 32). 
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Figure 31: Schematics and Photograph of the HUVEC Surface Seeding Device. 
 
 
Figure 32: Fluorescence/Phase Contrast Overlay of HUVECs Seeded on the Surface of a Collagen Microthread. After 
seeding with HUVECs for 4 hours, threads were rinsed in PBS and inspected using fluorescence microscopy for cells. Orange 
fluorescence indicates presence of DiI-Ac-LDL positive HUVECs (left panel). Negative controls without HUVECs seeded on the 
microthread surface had no fluorescence in the orange channel (right panel). Scale bar = 100m. 
 
After developing methods to effectively embed fibroblasts within and seed endothelial cells 
on the surface of collagen microthreads, it was necessary to validate the utility of fluorescence 
microscopy as the chosen characterization method throughout this study. Previously, 
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microthreads have demonstrated autofluorescence that has impaired analysis by fluorescence 
microscopy. An unstained, acellular thread was analyzed for autofluorescence in the green and 
orange channels. Limited, if any, autofluorescence in the green and orange channels was found 
(as shown in Figure 33). 
 
Figure 33: Acellular Control Microthread. Phase contrast/fluorescence overlaid images of an acellular thread. Limited 
fluorescence was observed in the green (left panel) and orange channel (right panel). Thread boundaries indicated by dashed 
lines. Scale bar = 100μm. 
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6. Final Design & Validation 
6.1 Co-Culture Studies 
The protocols developed through the pilot studies demonstrated the ability to extrude the 
HDF-populated thread scaffolds under sterile conditions, seed HUVECs on the surface of 
collagen threads, visualize cells both within and on the surface of the threads, and distinguish 
between the two cell types. Samples were collected at 24-hour time points for up to 3 days of co-
culture, as this is the time point at which tubule formation has been observed in similar collagen 
scaffolds [46]. The methods described in this section detail the team‘s final protocols for creating 
and analyzing the collagen microthread-based co-culture system (as shown in Figure 18). 
 
6.1.1 Cell Culture of HDFs and DiI-Ac-LDL-Labeled HUVECs 
Human dermal fibroblasts (HDFs, primary isolates from neonatal foreskin tissue) at passage 
12 and human umbilical vein endothelial cells (HUVECs, primary isolates, Lonza, Mapleton, IL) 
at passage 8 were used in this study. HDFs were cultured in DMEM (Mediatech, Herndon, VA) 
supplemented with 10% FBS (PAA, Ontario, Canada) and 1% penicillin/streptomycin 
(Mediatech, Herndon, VA). At 90% confluence, the HDFs were trypsinized and re-suspended at 
a concentration of 180,000 cells/mL. HUVECs were cultured with EGM media (Lonza, 
Mapleton, IL) at 37°C. At 80% confluence, the HUVECs were trypsinized and re-suspended at a 
concentration of 66,000 cells/mL. To differentiate between the two cell types, the HUVECs were 
pre-loaded with DiI-Ac-LDL prior to surface seeding. The HDFs were not to be labeled with 
MitoTracker in the co-culture system because it would appear in the same color channel as the 
phalloidin stain (described in 6.1.4 Fluorescent Labeling of Cell Cultures). 
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6.1.2 Fabrication of HDF-Populated Microthreads Using Cold-Mix Extrusion 
The final design consisted of a multi-step approach; the first step was to create HDF-
populated collagen microthreads (as shown in Figure 34). 
 
 
Figure 34: Step I – Embedding of HDFs within Collagen Microthreads 
Fibroblast-populated self-assembled collagen threads were produced using the novel cold-
mix extrusion method previously described and shown in Appendix C. Acid-soluble type I 
collagen was mixed with 5X DMEM and human dermal fibroblast cell suspension at a 4:1:3 
ratio. The three solutions were mixed thoroughly and extruded through a polyethylene tube with 
inner diameter of 0.86 mm into fiber formation buffer (FFB; pH 7.42, 135 mM NaCl, 30 mM 
TrizmaBase, and 5 mM NaPO4 dibasic; Sigma, St. Louis, MO). The threads were incubated for 
30 minutes in FFB at 37°C before transfer to DMEM culture media. These HDF-populated 
threads were cultured for 24 hours prior to seeding HUVECs on the thread surface. Acellular 
control threads were also extruded using the same method, substituting DMEM for the cell 
suspension. Samples were fixed 4 hours after extrusion and at 24 hour time points thereafter and 
processed for analysis (Figure 27).  After 48h of incubation, samples were fixed and processed to 
visualize cell nuclei and actin as shown in Figure 35. 
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Figure 35: HDF Monoculture Images. HDF-seeded collagen threads after 48 hours of culture at low (left) and high (right) 
magnification. White arrow indicates an HDF in the plane of focus. Samples were stained with phalloidin (actin; green) and 
Hoechst (nuclei; blue). Dashed lines indicate thread boundaries. 
6.1.3 HUVEC Surface Seeding 
The second step was to seed endothelial cells on the surface of the fibroblast-populated 
collagen microthreads (as shown in Figure 36). 
 
Figure 36: Step II – Surface-Seeding of HUVECs on Collagen Microthreads. 
After 24 hours in culture in DMEM culture media, acellular control threads and HDF-
populated threads were transferred to a custom-built PDMS seeding device for surface seeding. 
The device provided a constrained volume and geometry to facilitate cell contact and adhesion to 
the curved surface of the collagen microthreads. One hundred microliters of the HUVEC 
suspension were pipetted into each channel and the threads were incubated for 4 hours. The 
microthreads were then washed in PBS and transferred to EGM (CC3124, Lonza, Mapleton, IL) 
media for culture at 37°C. Cultures were fixed 48 hours after HUVEC seeding and processed for 
analysis (Figure 37). 
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Figure 37: HUVEC Monoculture Images. HUVEC-seeded collagen threads after 48 hours of culture at low (left) and high 
(right) magnification. White arrow indicates a HUVEC in the plane of focus. Samples were stained with phalloidin (actin; green) 
and Hoechst (nuclei; blue). HUVECs were labeled with DiI-Ac-LDL (orange). Dashed lines indicate thread boundaries. 
 
6.1.4 Fluorescent Labeling of Cell Cultures 
Cell-seeded collagen microthreads were removed from culture every 24 hours for 
observation. Each sample was placed on a glass slide, fixed with 4% paraformaldehyde, and 
stained with phalloidin to visualize cell morphology and Hoechst to visualize cell nuclei. This 
staining is in addition to the DiI-Ac-LDL labeling of HUVECs. 
 
6.1.5 Fluorescent Imaging 
Standard fluorescence microscopy was initially used to visualize stained samples. Due to the 
3D structure of the collagen threads, a more effective method of visualization was needed. To 
accomplish this, confocal fluorescence microscopy was also performed on the threads. This type 
of microscopy allows for single planes of the sample to be imaged with minimal interference 
from out-of-focus fluorescing regions of the sample. 
Fluorescent imaging of the cell-seeded constructs confirmed embedding of HDFs and surface 
attachment of HUVECs at all time points. HDF presence was determined by the co-localization 
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of the actin (green) with a nucleus (blue). HUVECs were distinguished by the added presence of 
DiI (orange). 
HDF and HUVEC mono-culture control experiments were performed to validate HDF 
embedding and HUVEC surface seeding methods. Figure 27 shows an HDF-seeded thread 
construct 4 hours and 24 hours after extrusion. The HDFs at 4 hours after extrusion exhibited 
very limited spreading, however an increasingly spread morphology was observed after 24 and 
48 hours of culture (Figure 35). Standard fluorescent images of the HDF-seeded threads included 
fair amounts of unwanted signal from out-of-focus cells. This suggested that the HDFs were 
distributed at different depths within the thickness of the thread and motivated the use of 
confocal microscopy for clearer images. Figure 37 shows an acellular collagen thread 48 hours 
after HUVEC seeding. Unlike the HDF monoculture threads, the majority of HUVECs appeared 
in the same plane of focus. 
Figure 38 shows an HDF- and HUVEC-seeded collagen thread after 48 hours of co-culture. 
Visualization throughout the thickness and along the length of the thread suggested uniform 
seeding of both embedded HDFs and surface-seeded HUVECs. Further characterization of the 
samples with confocal microscopy can be seen in Figure 39.  
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Figure 38: HUVEC- and HDF-Seeded Collagen Threads after 48 Hours of Co-Culture. Images were taken at low (left) and 
high (right) magnification. White arrows indicate HUVECs and HDFs in the plane of focus. Samples were stained with 
phalloidin (actin; green) and Hoechst (nuclei; blue). HUVECs were labeled with DiI-Ac-LDL (orange). Dashed lines indicate 
thread boundaries. 
 
 
 
Figure 39: Confocal z-Stack Overlay of HUVEC- and HDF-Seeded Collagen Threads after 24 Hours of Co-Culture. 
Samples were stained with phalloidin (actin; green) and Hoechst (nuclei; blue). HUVECs were labeled with DiI-Ac-LDL 
(orange). Dashed line indicates approximate thread boundary. 
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6.2 Achieving Specific Aims 
 
Specific Aim 1: Provide a 3-D culture environment for therapeutic cell types by embedding 
one of the cell types in a collagen microthread. 
Achievement 1: The established approach for collagen microthread fabrication consists of 
extruding a collagen suspension through small diameter tubing in a non-sterile environment. 
Our group developed a process where we can incorporate cells within the collagen 
microthread. This method also allows microthreads to be fabricated in a sterile environment, 
which is crucial for long-term cell culture. It also preserved cell viability and thread integrity 
through control of the extrudants and extrusion rate, as well as the temperature, pH, and 
osmolality of the extrusion bath. 
 
Specific Aim 2: Seed second cell type on the surface of a collagen microthread. The 
objective of this aim is to develop a seeding technique that has the potential to more 
effectively seed a chosen cell type on the surface of the microthread. 
Achievement 2: A novel seeding device was designed, optimized, and manufactured by our 
group. This device allowed HUVECs to be seeded on the surface of hydrated collagen 
microthreads by providing a confined geometry and volume. 
 
Specific Aim 3: Demonstrate the ability to maintain a long-term cellular co-culture system. 
Achievement 3: Utilizing the novel microthread extrusion process and seeding device as 
described previously in Achievement 1 and 2, a streamlined process has been developed to 
fabricate collagen microthreads that function as co-culture systems with the chosen cell 
types. This novel fabrication method allows for construction of structurally-stable collagen 
microthreads containing embedded HDFs and surface-seeded HUVECs.  
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7. Discussion 
7.1 Project Discussion 
The main focus of this project was on the development of methods that would allow for the 
construction and subsequent characterization of a co-culture system on collagen microthreads to 
facilitate neovascularization. Methods of independently seeding each cell type were developed, 
validated, and then combined to create the final co-culture system. Analysis techniques based on 
fluorescent labeling of the samples were then used for system characterization. 
All fluorescent images of the co-culture samples confirmed the presence of HDFs within, and 
HUVECs on the threads at all time points. Changes in HDF and HUVEC morphology were 
observed in both mono- and co-cultured threads as a function of time. These results were 
interpreted to also indicate the viability of both cell types even though no direct assays for cell 
viability were performed. This suggests that the media diffusion through the threads is sufficient 
enough to support cell growth and possibly proliferation. However, further studies involving 
more direct monitoring of cell viability and proliferation—such as a Live/Dead stain and Ki-67 
expression respectively—could determine this. If both cell types were indeed proliferating and 
exchanging soluble factors via diffusion, pro-angiogenic co-culture effects, such as tubule 
formation and sprouting can be observed. Analysis of tubule formation would require detailed 
imaging techniques but has been performed before [6, 46]. 
Initial assessments of the co-cultured microthread constructs were performed using standard 
fluorescence imaging. However, due to the exceptional thickness of the samples, confocal 
microscopy was used. This type of microscopy allows for the imaging of one plane of focus at a 
time, greatly minimizing the signal received from out of focus regions of interest. The technique 
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also allows for a stack of images to be taken of the sample and then reconstructed into a 3D 
representation, played in sequence as a movie, or overlaid into a z-stack (Figure 39). 
Confocal imaging of the co-culture samples confirmed the locations of specific cell types on 
the threads. Several z-stacks were taken at different locations along co-cultured threads and 
indicated the localization of HUVECs on the top, bottom, and sides of the thread. HDFs were 
localized within the thread at almost all depths. This confirmed the successful independent 
seeding of both cell types. The HDFs appeared to be distributed throughout the body of the 
thread in a fairly uniform manner, while the HUVEC surface-seeding exhibited limited 
uniformity with cells often localized on one or a few sides of the microthread in a monolayer 
configuration. This was possibly due to the geometry of the seeding device. While the device 
provides an efficient way to get a high concentration of cells onto the surface of the thread, their 
distribution on the thread surface is limited by the fact that the threads are cylindrical structures 
statically located at the bottom of a V-shaped channel under a cell suspension. The most likely 
explanation for this deficiency is that the topside of the thread was exposed to the cell suspension 
and received a monolayer of HUVECs while the other side received fewer cells because it faced 
the bottom of the channel. This could be eliminated by seeding both sides of the thread 
independently or by somehow making the seeding environment dynamic (rotating the thread, 
gently agitating the constructs, introducing media flow, etc.).  
To properly gauge the angiogenic potential of these constructs, analysis of tubule formation 
or endothelial sprouting must be performed. This could be done by utilizing UEA-I lectin [46] to 
stain the membranes of the HUVECs prior to imaging. Reliable tubule formation assays coupled 
with effective control of seeding efficiency would pave the way for studies on HUVEC dose-
response analysis to HDF seeding concentrations to determine which seeding ratios produce 
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constructs with the greatest angiogenic potential. Also related to this potential would be the 
degree to which the seeded cells alter the mechanical properties and composition of the 
microthread scaffold. Angiogenesis involves the remodeling of surrounding tissue through the 
secretion of MMPs, TIMPs, and other matrix-altering proteins. Future quantification of these 
changes would be invaluable for advancing our understanding of angiogenesis as well as 
determining how effective the co-cultured thread constructs would be at promoting angiogenesis 
and related processes in vivo. In addition, identifying and possibly being able to modify the 
mechanical properties of co-cultured microthreads would enable further development of 
implantation procedures. 
Several limitations of this technology do exist however. In the context of a cellular therapy to 
promote angiogenesis in vivo, the threads lack in that they can only deliver a relatively small 
volume of cells to the area of interest. This may be offset by delivery of multiple threads but only 
marginally. Another limitation arises from cell and material sourcing. To eliminate any chances 
of rejection, the cells and collagen used for the therapy must be autologously sourced. 
Fibroblasts may be easily obtained from the patient‘s skin but endothelial cells may be harder to 
obtain, and autologous HUVECs are not readily available for the majority of patients. In terms of 
a bench top model for angiogenesis, this technology encounters a different set of limitations. 
First, even though the co-culture system utilized is pro-angiogenic, angiogenesis is defined as the 
formation of new blood vessels from existing ones, thus the eventual formation of an actual 
blood vessel would be unlikely. Also, the system by itself lacks any analogue for flowing blood 
which is a component that is probably essential to proper angiogenesis in vivo.  
The localization and changes in morphology of both cell types after 48 hours of co-culture 
demonstrate that the HDF/HUVEC co-culture system was effectively translated to a collagen 
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microthread scaffold. This technology, in particular methods to independently seed two cell 
types, could also be utilized to construct threads for housing and studying other co-culture 
systems, not just pro-angiogenic ones. This opens up countless possibilities for creating easily 
deliverable cellular therapies and studying other in vivo physiologic mechanisms. 
One point of note, though not related to the goal of the project, is the fluorescent properties 
of the collagen microthreads. While thread autofluorescence was minimal and did not 
significantly interfere with observing the various fluorescent labels used to image cells, 
interesting fluorescent patterns were apparent in unseeded threads that were stained as controls. 
An example of this is shown in Figure 40.  
 
Figure 40: Fluorescent Image of an Unseeded Collagen Microthread Stained with Hoechst. 
Small filaments of about 50 μm in length appeared to be dispersed throughout the thickness 
of the thread, and appeared in the blue channel of threads stained with Hoechst. These filaments 
also appeared in the red channel when threads were stained with ethidium bromide (the DEAD 
stain from the LIVE/DEAD assay by Invitrogen). Appearance of these filaments was attributed 
to non-specific binding of the stains used; however their presence under Hoechst and ethidium 
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bromide staining suggests that they may be some kind of nucleic acid. Fluorescent analysis of the 
cell cultures was minimally affected by this unwanted noise because Hoechst-stained cell nuclei 
have a very distinct round shape and were generally brighter. A cell was defined as the co-
localization of a blue Hoechst-stained nucleus with green f-actin fibers stained with phalloidin. 
7.2 Impact Analysis 
In addition to our experiments, an impact analysis was conducted to relate this project to 
global concerns. In this analysis, we address economics, environmental impact, societal 
influence, political ramifications, ethical concerns, health and safety issues, manufacturability, 
and sustainability. 
Economics 
The patient‘s perceived ―willingness to pay‖ figures greatly into the overall economic value 
of this technology.  The behavioral economic prospective theory shows that if one were to gage a 
person‘s reaction to the resultant lose or gain from the same reference point; loss is far more 
emotionally devastating than the emotional reward from the gain. This is relevant to the co-
culture technology because the devastation of losing tissue function will, invariably, outweigh 
the emotional loss associated with losing a small sum of money, increasing the patient‘s 
willingness to pay for a desirable solution. 
Environmental Impact 
Co-culture will have a minimal environmental impact. The major environmental impacts can 
be found within the sustainability section of this report. Other environmental impacts can include 
the fact that if this device makes it to market, it would improve the lifespan of the patients. With 
more people living longer, the environment could be negatively impacted due to the waste that 
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humans produce on a daily basis. This could also adversely affect the scarce resources such as oil 
and create a strain on the economy. 
Societal Influence 
The co-culture system has the potential to greatly affect the ordinary person. By regenerating 
damaged tissue in patients, their quality of life will improve as will the lives of all who care 
about them. The emotional and social ramifications of this device could have strong potential if it 
goes to market. 
Political Ramifications 
This device has minimal political ramifications currently. It is possible that one day, when 
the manufacturing process is streamlined and perfected, that this could make a significant 
difference in countries around the world. Once it is streamlined, not only would European 
countries be able to utilize this device, but third-world countries maybe be able to use this 
technology as well.  
Ethical Concerns 
There are minimal ethical concerns that can be associated with this device. With the recent 
change in the policy on embryonic stem cell research, it is possible that this co-culture system 
could be called into question due to the fact that it has potential to utilize these cells. If this 
avenue is not pursued, then that concern will be nullified.  The other ethical concern is dependent 
upon potential patient‘s religions. This is due to the fact that taking cells from a patient and 
utilizing them in a biomedical capacity can conflict with their particular religion‘s belief system. 
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Health and Safety Issues 
The co-culture system was designed with the improvement of a patient‘s overall quality of 
life in mind. This system in theory should greatly improve a patient‘s health by repairing 
ischemic or infarcted tissues. With regards to the safety of this product, that will be deduced 
through extensive animal and clinical trials run in conjunction with the FDA. This will ensure 
that the invention is safe for patients and allow for the product to receive an HCPCS code, which 
allows for the system to be covered by insurance companies.  
Manufacturability 
Standard collagen microthreads are currently manufactured in a 3-day process, by hand and 
in small batches, using an extrusion system developed by Professor Pins of WPI.  Microthreads 
are manufactured on location; the threads are not prefabricated at this point due to concerns with 
maintaining the threads in a sterile environment.   While the novel process described in this 
report to create the co-cultured collagen microthreads takes only two days, it is unclear as of now 
how long co-cultured threads would need to be incubated before being implanted. This 
uncertainty is due to the early stages of the production of the threads and will improve as more 
research is conducted as the project moves forward. 
 When clinical trials occur, the microthreads will have to be manufactured in a contained, 
aseptic environment using collagen and reagents that are approved for clinical use. It is hoped 
that a bioreactor will ultimately be designed to hold microthreads and seed them with a patient‘s 
own cells. 
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Sustainability 
There are multiple definitions for sustainability depending on which aspect of the business 
sector one is looking at. For the scope of this project, the definition that was chosen was ―using 
methods, systems and materials that won't deplete resources or harm natural cycles‖. Using this 
description, the co-culture system can be analyzed for its conformance to sustainability. Since 
the collagen and the cells are both naturally occurring and can be derived from patients 
themselves or bovine specimens, these resources are renewable and will not be depleted. Cells 
are capable of regenerating and the collagen can be collected in a multitude of eco-friendly ways. 
In addition to this, the 1mL syringes that are used once and then discarded can be sent to a 
reprocessing plant and recycled. This increases the sustainability of the extrusion system and is 
an added benefit to the product.  
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8. Conclusions & Recommendations 
The main objective of this project was to develop a co-culture system for cell delivery using 
biopolymer microthreads as scaffolds. After extensive research, the team determined that 
HUVECs and HDFs were the best candidates for co-culture due to their well documented pro-
angiogenic potential. Combining this system with a novel approach to microthread extrusion, the 
team demonstrated the ability to fabricate structurally stable collagen microthreads while 
retaining cell viability. The team was also able to design and implement an effective surface-
seeding device. This device allowed HUVECs to be seeded on the surface of hydrated collagen 
microthreads by providing a confined geometry and volume. A set of characterization protocols 
were also developed to assess cell viability, morphology, and migration within the co-culture 
system. 
Future work on improving the co-culture system may include in vitro analysis of tubule 
formation by extending culture time and developing a UEA-1 lectin staining protocol. This type 
of lectin binds specifically to the surface of endothelial cells, which would allow for 
visualization of tubule formation [46].  Seeding efficiency of both methods should also be 
analyzed, as it is vital for future development of the co-culture system. The ability to control 
seeding density would allow for the study of HUVEC tubule formation as a dosed-response to 
HDF seeding concentrations. Cell-cell and cell-matrix interactions should also be conducted in 
the future to characterize the extent to which angiogenesis occurs in the system. Finally, 
mechanical tests such as uniaxial testing, and degradation studies should be performed. 
 
84 
Bibliography 
 
[1] A. H. Association, "Heart Disease and Stroke Statistics Update," A. H. Association, Ed., 2009. 
[2] J. C. Page, B. Newswander, D. C. Schwenke, M. Hansen, and J. Ferguson, "Retrospective analysis of 
negative pressure wound therapy in open foot wounds with significant soft tissue defects," Adv Skin Wound 
Care, vol. 17, pp. 354-64, Sep 2004. 
[3] K. A. Jackson, S. M. Majka, H. Wang, J. Pocius, C. J. Hartley, M. W. Majesky, M. L. Entman, L. H. 
Michael, K. K. Hirschi, and M. A. Goodell, "Regeneration of ischemic cardiac muscle and vascular 
endothelium by adult stem cells," J Clin Invest, vol. 107, pp. 1395-402, Jun 2001. 
[4] D. A. Taylor, B. Z. Atkins, P. Hungspreugs, T. R. Jones, M. C. Reedy, K. A. Hutcheson, D. D. Glower, and 
W. E. Kraus, "Regenerating functional myocardium: improved performance after skeletal myoblast 
transplantation," Nat Med, vol. 4, pp. 929-33, Aug 1998. 
[5] E. A. Phelps and A. J. Garcia, "Update on therapeutic vascularization strategies," Regen Med, vol. 4, pp. 
65-80, Jan 2009. 
[6] O. Velazquez, R. Snyder, Z. Liu, R. Fairman, and M. Herlyn, "Fibroblast-dependent differentiation of 
human microvascular endothelial cells into capillary-like 3-dimensional networks.," FASEB J, vol. 16, pp. 
1316-8, Aug 2002. 
[7] S. Soker, M. Machado, and A. Atala, "Systems for therapeutic angiogenesis in tissue engineering," World J 
Urol, vol. 18, pp. 10-8, Feb 2000. 
[8] J. H. Distler, A. Hirth, M. Kurowska-Stolarska, R. E. Gay, S. Gay, and O. Distler, "Angiogenic and 
angiostatic factors in the molecular control of angiogenesis," Q J Nucl Med, vol. 47, pp. 149-61, Sep 2003. 
[9] G. D. Yancopoulos, S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash, "Vascular-specific 
growth factors and blood vessel formation," Nature, vol. 407, pp. 242-8, Sep 14 2000. 
[10] O. C. Velazquez and M. Herlyn, "The vascular phenotype of melanoma metastasis," Clin Exp Metastasis, 
vol. 20, pp. 229-35, 2003. 
[11] L. E. Harry and E. M. Paleolog, "From the cradle to the clinic: VEGF in developmental, physiological, and 
pathological angiogenesis," Birth Defects Res C Embryo Today, vol. 69, pp. 363-74, Nov 2003. 
[12] G. Vunjak-Novakovic, G. Altman, R. Horan, and D. L. Kaplan, "Tissue engineering of ligaments," Annu 
Rev Biomed Eng, vol. 6, pp. 131-56, 2004. 
[13] K. G. Cornwell, P. Lei, S. T. Andreadis, and G. D. Pins, "Crosslinking of discrete self-assembled collagen 
threads: Effects on mechanical strength and cell-matrix interactions," J Biomed Mater Res A, vol. 80, pp. 
362-71, Feb 2007. 
[14] R. B. Jennings, C. E. Ganote, and K. A. Reimer, "Ischemic tissue injury," Am J Pathol, vol. 81, pp. 179-98, 
Oct 1975. 
[15] Merriam-Webster, "Webster's Third New International Dictionary, Unabridged," 2002. 
[16] T. Mustoe, "Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications 
for therapy," Am J Surg, vol. 187, pp. 65S-70S, May 2004. 
[17] E. T. Hasche, C. Fernandes, S. B. Freedman, and R. W. Jeremy, "Relation between ischemia time, infarct 
size, and left ventricular function in humans," Circulation, vol. 92, pp. 710-9, Aug 15 1995. 
[18] S. Viskin and B. Belhassen, "Idiopathic ventricular fibrillation," Am Heart J, vol. 120, pp. 661-71, Sep 
1990. 
[19] D. K. F. Patricia Gonce Morton, Carolyn M. Hudak, Barbara M. Gallo, Critical Care Nursing: A Holistic 
Approach, 8th ed. Philadelphia, PA: Lippincott WIlliams & Wilkins, 2005. 
[20] M. Bosiers, K. Deloose, J. Verbist, and P. Peeters, "Percutaneous transluminal angioplasty for treatment of 
''below-the-knee'' critical limb ischemia: early outcomes following the use of sirolimus-eluting stents," J 
Cardiovasc Surg (Torino), vol. 47, pp. 171-6, Apr 2006. 
[21] G. Dangas and F. Kuepper, "Cardiology patient page. Restenosis: repeat narrowing of a coronary artery: 
prevention and treatment," Circulation, vol. 105, pp. 2586-7, Jun 4 2002. 
[22] C. Schonholz, J. S. Ikonomidis, C. Hannegan, and E. Mendaro, "Bailout percutaneous external shunt to 
restore carotid flow in a patient with acute type A aortic dissection and carotid occlusion," J Endovasc 
Ther, vol. 15, pp. 639-42, Dec 2008. 
[23] E. C. Perin, H. F. Dohmann, R. Borojevic, S. A. Silva, A. L. Sousa, G. V. Silva, C. T. Mesquita, L. Belem, 
W. K. Vaughn, F. O. Rangel, J. A. Assad, A. C. Carvalho, R. V. Branco, M. I. Rossi, H. J. Dohmann, and J. 
T. Willerson, "Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of 
autologous bone marrow mononuclear cells for ischemic cardiomyopathy," Circulation, vol. 110, pp. 
 
85 
II213-8, Sep 14 2004. 
[24] D. J. Mooney and H. Vandenburgh, "Cell delivery mechanisms for tissue repair," Cell Stem Cell, vol. 2, pp. 
205-13, Mar 6 2008. 
[25] M. J. Price, C. C. Chou, M. Frantzen, T. Miyamoto, S. Kar, S. Lee, P. K. Shah, B. J. Martin, M. Lill, J. S. 
Forrester, P. S. Chen, and R. R. Makkar, "Intravenous mesenchymal stem cell therapy early after 
reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic 
properties," Int J Cardiol, vol. 111, pp. 231-9, Aug 10 2006. 
[26] "Endoscopy," in Medical Reference Encyclopedia: University of Maryland Medical Center, 2008. 
[27] M. P. Linnes, B. D. Ratner, and C. M. Giachelli, "A fibrinogen-based precision microporous scaffold for 
tissue engineering," Biomaterials, vol. 28, pp. 5298-5306, Dec 2007. 
[28] Y. Liu, H. S. Ramanath, and D. A. Wang, "Tendon tissue engineering using scaffold enhancing strategies," 
Trends in Biotechnology, vol. 26, pp. 201-209, Apr 2008. 
[29] I. Yannas, Tissue and Organ Engineering in Adults. New York: Springer, 2001. 
[30] J. L. Drury and D. J. Mooney, "Hydrogels for tissue engineering: scaffold design variables and 
applications," Biomaterials, vol. 24, pp. 4337-4351, Nov 2003. 
[31] R. D. Harkness, "Biological functions of collagen," Biol Rev Camb Philos Soc, vol. 36, pp. 399-463, Nov 
1961. 
[32] C. H. Lee, A. Singla, and Y. Lee, "Biomedical applications of collagen," Int J Pharm, vol. 221, pp. 1-22, 
Jun 19 2001. 
[33] F. A. Auger, M. Rouabhia, F. Goulet, F. Berthod, V. Moulin, and L. Germain, "Tissue-engineered human 
skin substitutes developed from collagen-populated hydrated gels: clinical and fundamental applications," 
Med Biol Eng Comput, vol. 36, pp. 801-12, Nov 1998. 
[34] Y. P. Kato, D. L. Christiansen, R. A. Hahn, S. J. Shieh, J. D. Goldstein, and F. H. Silver, "Mechanical 
properties of collagen fibres: a comparison of reconstituted and rat tail tendon fibres," Biomaterials, vol. 
10, pp. 38-42, Jan 1989. 
[35] M. G. Dunn, J. B. Liesch, M. L. Tiku, and J. P. Zawadsky, "Development of fibroblast-seeded ligament 
analogs for ACL reconstruction," J Biomed Mater Res, vol. 29, pp. 1363-71, Nov 1995. 
[36] Y. P. Kato, M. G. Dunn, J. P. Zawadsky, A. J. Tria, and F. H. Silver, "Regeneration of Achilles tendon with 
a collagen tendon prosthesis. Results of a one-year implantation study," J Bone Joint Surg Am, vol. 73, pp. 
561-74, Apr 1991. 
[37] K. G. Cornwell and G. D. Pins, "Discrete crosslinked fibrin microthread scaffolds for tissue regeneration," 
J Biomed Mater Res A, vol. 82, pp. 104-12, Jul 2007. 
[38] G. H. Altman, R. L. Horan, H. H. Lu, J. Moreau, I. Martin, J. C. Richmond, and D. L. Kaplan, "Silk matrix 
for tissue engineered anterior cruciate ligaments," Biomaterials, vol. 23, pp. 4131-41, Oct 2002. 
[39] J. Hendriks, J. Riesle, and C. A. van Blitterswijk, "Co-culture in cartilage tissue engineering," J Tissue Eng 
Regen Med, vol. 1, pp. 170-8, May-Jun 2007. 
[40] S. M. Bauer, R. J. Bauer, and O. C. Velazquez, "Angiogenesis, vasculogenesis, and induction of healing in 
chronic wounds," Vasc Endovascular Surg, vol. 39, pp. 293-306, Jul-Aug 2005. 
[41] M. Oberringer, C. Meins, M. Bubel, and T. Pohlemann, "A new in vitro wound model based on the co-
culture of human dermal microvascular endothelial cells and human dermal fibroblasts," Biology of the 
Cell, vol. 99, pp. 197-207, Apr 2007. 
[42] T. Friis, B. Kjaer Sorensen, A. M. Engel, J. Rygaard, and G. Houen, "A quantitative ELISA-based co-
culture angiogenesis and cell proliferation assay," APMIS, vol. 111, pp. 658-68, Jun 2003. 
[43] A. Wenger, N. Kowalewski, A. Stahl, A. T. Mehlhorn, H. Schmal, G. B. Stark, and G. Finkenzeller, 
"Development and characterization of a spheroidal coculture model of endothelial cells and fibroblasts for 
improving angiogenesis in tissue engineering," Cells Tissues Organs, vol. 181, pp. 80-8, 2005. 
[44] A. A. Ucuzian and H. P. Greisler, "In vitro models of angiogenesis," World J Surg, vol. 31, pp. 654-63, Apr 
2007. 
[45] R. Auerbach, R. Lewis, B. Shinners, L. Kubai, and N. Akhtar, "Angiogenesis assays: a critical overview," 
Clin Chem, vol. 49, pp. 32-40, Jan 2003. 
[46] H. Liu, B. Chen, and B. Lilly, "Fibroblasts potentiate blood vessel formation partially through secreted 
factor TIMP-1.," Angiogenesis, vol. 11, pp. 223-34, 2008. 
[47] L. A. Kunz-Schughart, J. A. Schroeder, M. Wondrak, F. van Rey, K. Lehle, F. Hofstaedter, and D. N. 
Wheatley, "Potential of fibroblasts to regulate the formation of three-dimensional vessel-like structures 
from endothelial cells in vitro," Am J Physiol Cell Physiol, vol. 290, pp. C1385-98, May 2006. 
[48] E. Schonherr, L. Schaefer, B. C. O'Connell, and H. Kresse, "Matrix metalloproteinase expression by 
 
86 
endothelial cells in collagen lattices changes during co-culture with fibroblasts and upon induction of 
decorin expression," Journal of Cellular Physiology, vol. 187, pp. 37-47, Apr 2001. 
[49] O. Z. Lerman, R. D. Galiano, M. Armour, J. P. Levine, and G. C. Gurtner, "Cellular dysfunction in the 
diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to 
hypoxia," Am J Pathol, vol. 162, pp. 303-12, Jan 2003. 
[50] L. P. Dym CL, Engineering Design: A Project-Based Introduction: Wiley, 2003. 
[51] G. D. Pins, D. L. Christiansen, R. Patel, and F. H. Silver, "Self-assembly of collagen fibers. Influence of 
fibrillar alignment and decorin on mechanical properties," Biophys J, vol. 73, pp. 2164-72, Oct 1997. 
[52] T. Z. Wang, Z. Y. Xu, W. H. Jiang, and A. Q. Ma, "Cell-to-cell contact induces mesenchymal stem cell to 
differentiate into cardiomyocyte and smooth muscle cell," International Journal of Cardiology, vol. 109, 
pp. 74-81, Apr 2006. 
[53] S. Werner, T. Krieg, and H. Smola, "Keratinocyte-fibroblast interactions in wound healing.," J Invest 
Dermatol, vol. 127, pp. 998-1008, May 2007. 
[54] P. Shephard, B. Hinz, S. Smola-Hess, J. Meister, T. Krieg, and H. Smola, "Dissecting the roles of 
endothelin, TGF-beta and GM-CSF on myofibroblast differentiation by keratinocytes.," Thromb Haemost, 
vol. 92, pp. 262-74, Aug 2004. 
[55] R. Baffour, R. Pakala, D. Hellinga, M. Joner, P. Okubagzi, S. Epstein, and R. Waksman, "Bone marrow-
derived stem cell interactions with adult cardiomyocytes and skeletal myoblasts in vitro.," Cardiovasc 
Revasc Med, vol. 7, pp. 222-30. 
[56] S. Le Ricousse-Roussanne, J. Larghero, J. Zini, V. Barateau, P. Foubert, G. Uzan, X. Liu, M. Lacassagne, 
B. Ternaux, I. Robert, M. Benbunan, J. Vilquin, K. Vauchez, G. Tobelem, and J. Marolleau, "Ex vivo 
generation of mature and functional human smooth muscle cells differentiated from skeletal myoblasts.," 
Exp Cell Res, vol. 313, pp. 1337-46, Apr 2007. 
[57] S. G. Ball, A. C. Shuttleworth, and C. M. Kielty, "Direct cell contact influences bone marrow mesenchymal 
stem cell fate," International Journal of Biochemistry & Cell Biology, vol. 36, pp. 714-727, Apr 2004. 
[58] D. J. Brown, E. M. Rzucidlo, B. L. Merenick, R. J. Wagner, K. A. Martin, and R. J. Powell, "Endothelial 
cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation," 
Journal of Vascular Surgery, vol. 41, pp. 509-516, Mar 2005. 
[59] K. Alitalo, E. Kuismanen, R. Myllyla, U. Kiistala, S. Askoseljavaara, and A. Vaheri, 
"EXTRACELLULAR-MATRIX PROTEINS OF HUMAN EPIDERMAL-KERATINOCYTES AND 
FEEDER 3T3-CELLS," Journal of Cell Biology, vol. 94, pp. 497-505, 1982. 
[60] V. Valiunas, S. Doronin, L. Valiuniene, I. Potapova, J. Zuckerman, B. Walcott, R. Robinson, M. Rosen, P. 
Brink, and I. Cohen, "Human mesenchymal stem cells make cardiac connexins and form functional gap 
junctions.," J Physiol, vol. 555, pp. 617-26, Mar 2004. 
[61] H. Reinecke, E. Minami, V. Poppa, and C. Murry, "Evidence for fusion between cardiac and skeletal 
muscle cells.," Circ Res, vol. 94, pp. e56-60, Apr 2004. 
[62] G. Condorelli, U. Borello, L. De Angelis, M. Latronico, D. Sirabella, M. Coletta, R. Galli, G. Balconi, A. 
Follenzi, G. Frati, M. G. C. De Angelis, L. Gioglio, S. Amuchastegui, L. Adorini, L. Naldini, A. Vescovi, 
E. Dejana, and G. Cossu, "Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac 
muscle: Implications for myocardium regeneration," Proceedings of the National Academy of Sciences of 
the United States of America, vol. 98, pp. 10733-10738, Sep 2001. 
 
 
 
87 
Appendix A: Glossary 
 
3T3-J2 – A standard fibroblast line derived from mouse embryo tissue 
Alginate – A viscous gum widely used for cell immobilization and encapsulation 
Angiogenesis – The growth of new blood vessels from pre-existing vessels 
Angiotensin Converting Enzyme Inhibitor (ACE Inhibitor) – Any of a group of drugs that 
relaxes arteries by hindering the activity of certain enzymes 
Anticoagulant – A drug that prevents the clotting of blood 
Anti-platelet – A drug that inhibits or destroys blood platelets 
Atherosclerosis – A disease of the arteries characterized by deposits of fatty substances along 
artery walls, resulting in the narrowing of the vessels 
Autofluorescence – Naturally occurring fluorescent signal of a substance, such as collagen 
Biomaterial – A natural or synthetic material suitable for introduction into living tissue 
Cardiac – Pertaining to the heart 
Cardiac Myocyte – Heart muscle cell 
Cardiovascular Disease (CVD) – Any of a category of diseases that affect the heart or arteries 
Cerebral – Pertaining to the brain 
Chitosan – A polymer formed by chitin, a polysaccharide 
Collagen – A strong fibrous protein that provides an extracellular matrix for tissues and cells 
within the body 
Confocal Microscopy – An optical imaging technique used to reconstruct microscopic three-
dimensional structures 
Cutaneous – Pertaining to the skin 
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Cytokine – Any of several protein growth factors that stimulate proliferation, especially of 
endothelial cells, and that promote angiogenesis 
Cytotoxic – Cell-killing; toxic to cells 
DiI-ac-LDL – An orange fluorescent stain specific to endothelial cells 
Dulbecco’s Modified Eagle’s Medium (DMEM) – A concentrated solution of amino acids, 
vitamins and supplementary components, such as salts 
Endothelial Cell– A specialized type of cell that lines the circulatory system 
Extracellular Matrix – The part of a tissue that provides structural support to cells, in addition 
to other important functions 
Fibrin – A fibrous protein that assists with blood clotting 
Fibroblast – A type of cell that synthesizes the extracellular matrix and plays a critical role in 
wound healing 
Hoechst – A blue fluorescent dye that stains cell nuclei, to visualize cell location 
Human Mesenchymal Stem Cell (hMSC) – A cell that can differentiate into many cell types, 
that is isolated from bone marrow 
Hydrogel – A network of highly absorbant natural or synthetic polymer chains that are water-
insoluble 
Induced Pluripotent Cell (iPSC) – A type of stem cell artificially derived, usually from an adult 
somatic cell 
Infarction – An area of tissue that is dead due to lack of blood flow 
Ischemia – The restriction in blood supply that causes damage or death to tissue 
Keratinocyte – A type of cell found in the epidermis (skin); also called ―basal cell‖ 
Mesenteric – Pertaining to the small intestines 
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MitoTracker – A green fluorescent dye utilized to facilitate non-terminal visualization of cells 
Morphology – The shape of a cell; evaluation of morphology can indicate cell viability 
Myocardial Infarction – A heart attack; death of cardiac tissue 
Necrosis – Death of cells or living tissue 
Neovascularization – The formation of functional microvascular networks 
Perfusion – The process of blood flow to biological tissue 
Phalloidin – A green fluorescent dye that stains actin to facilitate visualization of cell 
morphology 
Phenotype – An observable characteristic or trait of an organism or cell 
Polycarbonate – A thermoplastic polymer that is often used in medical applications as it is not 
cytotoxic, and is easy to manufacture, machine and sterilize 
Polymerization – The process by which individual monomers link into chained polymers 
Protease – Any of a group of enzymes that assists in the creation of proteins by hydrolysis of 
peptide bonds 
Regenerative Therapy – A method of treatment that focuses on the restoration of tissue 
Scaffold – A temporary framework that provides support 
Sickle-cell Disease – A blood disorder characterized by abnormal, rigid red blood cells that 
results in a lack of perfusion 
Skeletal Muscle Cell – A cell found in the skeletal muscle 
Smooth Muscle Cell – A cell found in muscle tissue that performs functions not under direct 
voluntary control 
Stent – A tube inserted into a blood vessel to prevent or counteract a localized blood flow 
constriction by holding the vessel open 
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Tachycardia – A condition in which the resting heart rate exceeds the normal range, leading to 
insufficient blood supply 
Thrombosis – The formation of a blood clot inside a blood vessel, obstructing the flow of blood 
through the circulatory system 
Ulcer – A discontinuity in the skin; most prevalent types are diabetic ulcers (localized slowing or 
stopping of blood flow), pressure ulcers (lesions to the skin caused by unrelieved pressure; 
―bedsore‖), and venous ulcers (occurs due to improperly functioning valves in veins, usually 
in the legs) 
Vascular – Relating to the blood vessels of the body 
Vasculogenesis – The process of new blood vessel formation where no pre-existing vessels 
occur; compare to ―angiogenesis‖ 
Vasodilator – A type of drug that widens blood vessels by relaxing the smooth muscle cells 
within the vessel walls 
Ventricular Fibrillation – A condition in which the contraction of cardiac muscle in the 
ventricles of the heart is uncoordinated, resulting in trembling rather than effective 
contraction 
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Appendix B: Client Feedback 
November 6, 2008 
Dermal Fibroblasts 
- HUVECS can be cultured in defined media,  
o Supplements 
- Angiogenesis: Dermal fibroblasts cultured with HUVECs 
o Big correlation between increase in profusion and increase in function 
hMSCs 
- Common media 
- Previous co-culture studies with many different cell types 
- Lots done with hMSCs 
- What is the enhanced benefit of doing this – why go through with co-culturing? 
Smooth muscle cells 
- All kinds of media 
- Mature fibroblasts: what is the benefit of that co-culture? 
o What are we measuring, who cares 
- Markers are specific – hard to distinguish between smooth muscle cells and fibroblasts in 
a co-culture system 
Keratinocytes 
- Co-culture with fibroblasts, lots of reciprocal expression mechanisms 
- Differentiates fibroblasts to myofibroblasts with keratinocytes 
- Increased tension generated by cells in differentiation 
Skeletal myoblasts 
- Desmin – all muscle cells, way to show difference between muscle cells and fibroblasts 
- When co-cultured with cardiomyocytes  Cx43 (measurable outcome) 
Endothelial cells 
- Previous co-culture studies with many different types of cells 
- Vasculogenesis 
- Induce MSCs to differentiate into SMCs 
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3T3-J2s 
- Primary mouse embryonic fibroblast 
- Secrete growth factors 
Cardiac myocytes 
- Hypertrophic – cells get really big, or they make more cells, or they‘re upsetting matrix 
o Hypertrophy – heart gets enlarged 
iPSC 
- Cultured on a feeder layer 
- Similar to embryonic stem cells 
Embryonic stem cells 
- Grown on mouse fibroblast feeder layer 
Criteria to think about when picking particular cells 
- Culture time 
- Cost 
- Availability 
- Measurable outcome 
o Matrix: cell-type one, cell-type two, quantitative outcomes 
- Purposeful (will do something in the heart) 
o All these things help the heart 
o Rank the ways they help, what does the most/best 
- Rationale for using the combinations 
- Growth factors will lose productivity, but cells will keep making useful/useable products 
- In vivo, there‘s never just one cell type 
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November 13, 2008 
Cell types 
- Assume cost is a constraint (also objective) 
o Which best meets criteria? 
- Endothelial cells and dermal fibroblasts meet that criteria 
o Check different proliferation rates in 2D versus 3D, collagen vs. synthetic 
 Contract lattice (directionality) 
 Can you control it? 
o (HUVECs) 
o Also ease of co-culture, etc. 
 Fibroblasts grow in just about everything 
 Grow fast, easy 
 Have GFP modified dermal fibroblasts 
 Will make images, assays easier 
 Acetylated LDL 
o Can look at a lot of stuff to compare (assays) 
o Neovascularization (good!) 
Quantitatively assess project objectives/constraints (refer to Cell Adhesion MQP) 
o 5 point scale (ex.) 
 Cost effective:  0 = scale (+$1000), 1 = ($900-1000), etc 
o Time efficient 
o User friendly 
o (second tier objectives) 
o If satisfies all 2nd tier objectives, then it gets highest score, all but one gets 2nd highest 
score, etc 
o Create scoring matrix for cell types 
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November 20, 2008 
Cell combinations: 
 Redo filter system? 
o Maybe weight constraints for chart 
o Did we turn all objectives into constraints? 
o Work on design rubric 
Design alternatives: 
 Used the same constraints, categorized broadly and eliminated based on constraints, 
condensed 
 Best of Class chart 
 For report: 
o Pros and cons 
o Must be justified objectively 
 Steer away from ―intuition driven‖ decisions 
Report documentation 
 Functions/means 
 Design-driven changeable system 
 Bench-top model 
o User requirement 
 Stable culture system 
 Culture cells in and/or on threads and make numerous 
measurements 
o Important benchmarks: 
 One cell type inside the thread 
 Shearing? 
 Embedding cells inside threads (similar to spheres?) 
 More important than co-culture! 
o Can co-extrude both cell types 
o Extrude cells in 2 threads 
 Bundling/twisting 
 One cell type outside the thread 
 Characterization? 
o Angiogenesis 
o Readout will depend on design configuration 
o Have to consider desired endpoint (therapeutic) 
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December 2, 2008 
Input: Output: What to look for: How? 
Cellf-celle 
interactions 
 Angiogenesis  
(and inhibition) 
 Vessel formation: 
o Inhibition: MMP-9, ανβЗ 
o Enhancement: VEGF,  
TIMP-1, bFGF 
 Microscopy image analysis 
 Cell-specific markers 
 ανβЗ expression 
 Cell-cell contact   FGF assay from media 
 Transdifferentiation  Fibroblasts  
myofibroblasts 
 Microscopy  
o ED-A fibronectin expression 
 
 Benchmarks: 
o Fibroblasts inside 
o Endothelial cells outside 
o Combined 
 Enhanced angiogenesis – VEGF, TIMP-1, bFGF 
 Impaired angiogenesis - MMP-9, ανβЗ Ab,  
 Validate benefits of co-culture 
o Look at endothelial cell migration without fibroblasts? 
o Future work 
 
 
  
ανβЗ, ET-
1 νWF 
PECAM-1 
Endo-specific Lectin 
Mito-tracker 
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December 11, 2008 
 Configuration 
o Cell migration/diffusion model 
 ECs migrate extensively 
 ECs embed themselves 
o Bruce Albert‘s Molecular Biology of the Cell 
o VEGF is good 
o Soluble factors at work (combined model – Liu et al.) 
 Fibroblast conditioned media 
o TIMP-1 – increases angiogenesis via inhibition of MMP-9 
 Benchmarks 
o Fibroblasts inside 
o ECs outside 
o Then both 
 Proof of concept 
 Need to distinguish between the cells – ideas? 
o vWF (ECs) - red 
o α-SMA (fibroblasts) – green 
o DiI-ac-LDL – orange 
o Terminal? Any way to distinguish by non-terminal means? 
o Random sampling 
o Autofluorescence of the threads, want to check what they are to see what will work 
best 
o MitoTracker allows for lots less time 
 How they interact with each other 
 Day by day, how long it takes them to reach the center 
 Angiogenesis vs. vasculogenesis 
 What should we look for: 
o MitoTracker  
 Both on, both growing 
o Lectin 
 Can be injected into live animals 
 Use it to tag cells 
 Can add before seeding threads 
 Easier to get this stuff in while in tissue culture than on threads 
 Getting cells on – alternatives: 
o Meaghan‘s method 
o Migration 
 Bundle of threads, partially seeded partially not 
o Bundle of 4, 2 with endos, 2 with fibroblasts 
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January 21, 2009  
 Written document – clients 
o What we think: didn‘t really keep up with the background – part of it was lack of 
feedback 
 Critical decisions made at the end of the term, so writing was caught at weird 
time 
o Expectations for document? 
 Should fully represent efforts 
 Table of figures/tables  
 Project approach (theoretically) 
 Introduction 
 Bibliography 
 C-term Plan (us) 
o Finished extrusion with fibroblasts 
 Some confusion with images 
 Noise, thread interference 
o Optimized extrusion protocol 
 Done, but needs to be verified 
o Thread integrity, properties 
 Cold, neutral extrusion (mix all together first then extrude) 
 Double-check variables – temp, etc.  
 Collagen to total solution = 1:1 
o Extrudes better into FFB 
 135mM NaCl, 30mM Tris, 5mM NaPO4 
 Collagen gels better than straight into media 
 Waviness (accordion-ness) 
 Try to figure out how to get the kinks/coils out 
 Can cells remain viable in FFB? 
 Experiment from B-term said that cells can stay in such solutions for 
short times without dying 
 Checking cytotoxic effects 
o Experiments 
o Composition 
 Find balance of cell activity and polymerization 
 FFB to DMEM/FFB to 100% DMEM 
o Culture time 
 7 days? Too long 
 48-72 hours on/in threads instead 
 Create container to extrude threads into/seed ECs outside 
 PDMS gel with troughs 
 Autoclave? 
o Monitoring cell location 
 MitoTracker and Live/Dead (CytoTracker?) 
 Color – green MitoTracker, green Live/Dead 
 Need them to be alive, and need to know where they are  
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 Need them to be loaded with dye to track over time 
 What else can we look for? 
o How is it going to change? 
 Expect them to spread (good indicator) 
 Contracting collagen gel 
 Go to website for providers or call company 
o See if proteins express in dead cells  
o Methanol experiment to see if proteins express when cells are 
dead – methanol will fix cells 
 Metabolic dyes only express with metabolic processes 
o Short term (5 days?) 
o Can cells be re-dosed? At least with CytoTracker (2-3 days 
otherwise) 
 Also experiment with this? 
 Fluorescent reporter inside cell? 
o Plasmid? 
o Transducing fibroblasts (1-2 weeks) 
o Must have the right reporter, or they‘re just pretty cells 
o If cells are dead, do they still express? 
 Culture in parallel 
o Some to be Live/Dead, some for long-term monitoring 
 Co-culture assays 
o Different colors, etc. 
o Different kinds of dyes 
 Inside 
 Prelim tests (controls) 
 Outside 
 Prelim tests (controls) 
 Combined 
o Effects of co-culture 
o Project objectives 
 Would rather have things like how to move it, culture, etc. 
 Instead of long-term culture 
 Focus on all objectives for 2-3 days instead of some for 7 
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January 23, 2009 
 Methods 
o Hard because it‘s a process/series of procedures, not really a device 
 In, out, and together 
o In 
 Modify  extrusion process for our application and optimize 
 Cold-mix  
o Came about from trying other methods first 
o Show process, data, etc. 
 What we extrude into 
 Rate 
 Cell culture 
 Time 
 Threads 
 Integrity 
 Time for culturing 
o Out 
 How to seed cells 
 Culture device 
 Experiment: Testing of HDFs 
o Ethanol 
 Kill cells, see if MitoTracker still expressed 
 Just because we see MitoTracker, doesn‘t mean cells are alive 
 Also stain with Dead component of Live/Dead 
o PBS 
 Control 
 To check MitoTracker and Dead 
o FFB 
 Checking cytotoxicity 
 Important for optimization of thread extrusion process 
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February 11, 2009 
Future work: 
 Measurable outcome: tubule function 
o Everybody does it, so there‘s lots of ways to do it, stuff to look at, etc. 
o Replicate something else to benchmark, also make sure we know that what we‘re 
doing works 
o Separate fibroblasts from endos 
o On a gel or something 
o Collagen gel out of same material we‘re extruding, let it set then add endos on top 
 With and without fibroblasts 
 Good control image 
o Methods: 
 # of pixels occupied by tubules 
 Sprout length 
 Relative area and combined length of ECs involved in tubule 
formation 
 How much better than the control 
 Lots of detail in paper 
 Length of tubule lines – on planar surface 
o How to adapt to thread? 
o How do you know the cells aren‘t growing down? How do you know the 
spreading is planar? 
 Good question, appreciate the issue, next group should use con-focal 
scope 
o Dose response of fibroblasts  
 Hypothesize that fibroblasts are helping endos, if we can show it = 
awesome 
 Actual exact perfect numbers aren‘t really necessary at this point 
(optimization, etc) 
 Try with lots of different fibroblast concentrations, and kind of assume 
ECs are the same every time – if experiments don‘t come out similarly, 
then go back and tweak the cell-seeding stuff  
o Endos do this, and then all the cells do this other thing 
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Appendix C: Protocols 
Pre-loading of HDFs with MitoTracker 
1. Rinse cell culture 3X with sterile PBS 
2. Dilute MitoTracker with DMEM media to 0.05% (V:V) 
3. Deliver the MitoTracker solution to the dish and incubate in 37C for 2 hr 
4. Remove MitoTracker solution and rinse cell culture 2X with sterile PBS 
5. Resume culture in DMEM (10%FBS) 
 
 
 
Phase contrast/fluorescence overlay image of MitoTracker Green-loaded human dermal 
fibroblasts (left). Unloaded fibroblasts showed no autofluorescence in green channel (right). 
Scale bar = 100 μm. 
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Preliminary HDF-Collagen Co-Extrusion 
Materials: 
 10 mg/mL RTT collagen (0.4 mL) 
 5X DMEM 
To make:  
 
     
  
 
 1X DMEM (10% FBS) 
 Dermal Fibroblast suspension at 180,000 cells/mL 
 Fiber Formation Buffer 
 135 mM NaCl 
  30 mM TrizmaBase 
  5 mM NaPO4 dibasic  
 Sterile 1 mL syringes 
 Sterile 0.83 mm PE tubing 
 Syringe pump 
Methods: 
1. In a 4°C cold room, place 0.4 mL of 10 mg/mL RTT collagen in 1mL syringe 
2. Aliquot 0.1 mL of 5X DMEM 
3. Mix 0.1mL 5X DMEM and 0.3mL of cell suspension in second 1mL syringe 
4. Co-extrude at 0.25mL/min into 37°C 1X DMEM 
5. Incubate for 15 minutes, PBS rinse for 15 minutes 
6. Sacrifice for analysis 
 
Bright field/fluorescence overlay image of a thread 
containing MitoTracker-loaded HDFs (green) and 
stained with Hoechst (nuclei; blue); HDF presence 
was determined by the co-localization of 
MitoTracker-loaded cells with a nucleus. Smaller 
blue particles not associated with a MitoTracker-
positive HDF were identified as the result of non-
specific binding of Hoechst stain to impurities in the 
collagen. HDFs are indicated by white arrow heads 
and thread boundaries are highlighted by white lines. 
Scale bar = 100 μm  
DMEM Powder 13.48 g 
H2O 200 mL 
NaHCO3  3.7 g 
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Co-Extrusion Components Cytotoxicity Study 
Materials: 
 Dermal Fibroblast suspension at 180,000 cells/mL (Pre-loaded with MitoTracker) 
 10 mg/mL type I collagen 
 5X DMEM 
 1X DMEM 
 6-well plate 
Procedure: 
1. Put 1mL of cell suspension into each well 
2. Allow cells to adhere to plate surface for 4 hours 
3. Remove media from well and replace with 3mL one of the co-extrusion components 
(collagen, 5X DMEM, or 1X DMEM)  
4. Take observation using fluorescence microscopy after 10 minutes and compare 
morphology to initial morphology. 
 
 
 
 
 
 
 
Fluorescence images of 
MitoTracker-positive human 
dermal fibroblasts before (left 
column) and after (right 
column) 10 minutes of 
exposure to the co-extrusion 
components. No changes in 
morphology was observed. 
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Acellular Co-Extrusion into FFB 
Objective:  
To develop extrusion protocol that produces stable threads with long-term integrity. Extruding 
into FFB will provide time for the collagen thread to gel before being transferred to DMEM for 
culture. 
 
Measurable Outcomes: 
- Visual inspection for thread integrity 
- Ability of thread to be handled with forceps 
- Ability of thread to support its own weight when hung  
 
Materials: 
- (2) 1mL syringes 
- Fiber Formation Buffer (135mM NaCl, 30 mM Tris, 5mM NaPO4) 
- 0.86 mm (ID) PE tubing 
- 20G needle, with tip removed 
- Blending connector tip 
- 37°C water bath 
- Syringe pump 
 
 
Methods: 
1. Aliquot extrudants as shown above, keep at 4°C 
2. Mix 5X DMEM and 1X DMEM and place in 1 mL syringe; place collagen in another 1 
mL syringe 
3. Heat FFB in Petri dish to 37°C in water bath 
4. Assemble extrusion apparatus and extrude threads at 0.25mL/min 
 
 
5. Remove samples to 37°C 1X DMEM at designated time points 
Proportions Actual 
1 part 5X DMEM (on ice) 0.05 mL 
3 parts 1X DMEM (without cells) 0.15 mL 
4 parts 10 mg/mL collagen (on ice) 0.2 mL 
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Results: 
 
time  0 min 30 min 60 min 6 hr 
Batch1 extruded 
transfer to media 
- stable threads 
- stable threads 
- supports own weight 
- visible loss of integrity 
- ―frills‖ around thread 
- collagen film developing 
on surface of media 
-  able to be handled 
-  supports own weight 
Batch2 extruded --- 
transfer to media 
- stable threads 
 
 t = 60 min, Batch1 
 
  
t = 6 hr, Batch1 (30 min in FFB)  t = 6hr, Batch2 (60 min in FFB) 
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FFB Cytotoxicity Study 
Materials: 
 Dermal Fibroblast suspension at 180,000 cells/mL (Pre-loaded with MitoTracker) 
 FFB (3mL) 
o 135 mM NaCl 
o 30 mM TrizmaBase 
o 5 mM NaPO4 dibasic 
 PBS (3mL) 
 EtOH (3mL) 
 PBS (3mL) 
 6-well plate 
Procedure: 
1. Put 1mL of cell suspension into each well 
2. Allow cells to adhere to plate surface for 4 hours 
3. Deliver 3mL of reagent into individual wells: 
FFB PBS EtOH 
FFB PBS EtOH  
 
4. Incubate at 37°C 
5. Make observations under the microscope after 60 min  
6. Stain cultures with ‗Dead‘ component of Live/Dead stain (ethidium homodimer, EthD-1, 
red) 
 
Phase contrast/fluorescence overlay of MitoTracker Green-positive HDFs on tissue 
culture plastic exposed to FFB, PBS, or EtOH for 60 minutes (A, B, C, respectively). 
Samples were stained with ‗Dead‘ component of Live/Dead stain (ethidium 
homodimer, EthD-1, red) following incubation. Cells incubated in FFB and PBS 
exhibited no discernable difference in viability, whereas all cells exposed to EtOH were 
dead (with no MitoTracker signal present). Scale bar = 100 μm  
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Acellular and HDF-Collagen Cold-Mix Extrusion 
Materials: 
 10 mg/mL RTT collagen (0.4 mL) 
 5X DMEM 
To make:  
 
     
   
 
 1X DMEM (10% FBS) 
 Dermal Fibroblast suspension at 180,000 cells/mL 
 Fiber Formation Buffer 
 135 mM NaCl 
  30 mM TrizmaBase 
  5 mM NaPO4 dibasic  
 Sterile 1 mL syringes 
 Sterile 22G blunt-tip needle 
 Sterile 1.8 mL Eppendorf tube 
 Sterile 0.83 mm PE tubing (sterilized by rinsing 3X in 70% ethanol, then 3X in sterile 
PBS) 
 Syringe pump 
 
 
Procedure: 
1. Place 0.4 mL of 10 mg/mL type I RTT collagen (on ice) in sterile 1.8 mL 
Eppendorf tube 
2. Add 0.1 mL of 5X DMEM (on ice) to tube 
 
3. Add 0.3mL of DFs at 180,000 cells/mL in 1X DMEM (10%FBS) to tube 
4. Mix solutions thoroughly by pipette, careful to minimize any bubbles 
DMEM Powder 13.48 g 
H2O 200 mL 
NaHCO3  3.7 g 
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5. Leaving 0.2mL of air space (to accommodate length of PE tubing), draw entire 
solution into 1 mL syringe 
  
6. Assemble extrusion system by inserting blunt-tip needle into PE tubing 
 
7. Attach syringe to extrusion system and, using a syringe pump, extrude at 
0.25mL/min into 20mL of 37°C FFB in Petri dish 
  
8. Incubate for 30 minutes at 37°C, then transfer threads to 1X DMEM (10% FBS) 
and continue to incubate 
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Pre-loading of HUVECs with DiI-ac-LDL 
1. Rinse culture 3X with sterile PBS 
2. Mix 150uL of DiI-Ac-LDL with 6mL of EGM media (for each culture plate) 
3. Deliver DiI-Ac-LDL into culture 
4. Incubate for 4 hours 
5. Rinse 3X with PBS 
6. Culture HUVECs in EGM culture media 
 
 
 
Phase contrast/fluorescence overlaid image of human umbilical vein endothelial cells 
following DiI-ac-LD uptake (left panel). Unlabeled human umbilical vein endothelial 
cells exhibit no fluorescence in the orange channel (right panel). Scale bar = 100m. 
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HUVEC Surface Seeding 
Materials: 
 HDF-populated microthreads 
 Surface seeding device 
 HUVECs (66,000 cells/mL) 
 EGM media 
 Sterile forceps 
 
 
Procedure: 
1. Using sterile forceps, remove 3 cm of HDF-collagen thread from incubation to 
surface seeding device 
 
2. Pipette 100 L of HUVEC cell suspension in each seeding channel to cover entire 
length of thread 
 
3. Incubate surface seeding device at 37°C for 4 hours 
4. Carefully rinse threads with sterile PBS 
5. Using sterile forceps, transfer to EGM media for long-term culture 
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Thread Fixation and Fluorescent Staining Protocol 
 
1. Place threads on glass slides and fix in 4% Paraformaldehyde in PBS for 10 minutes. 
2. Rinse threads in PBS for 5 minutes. (3 times) 
3. Permeabolize samples with 0.25% Triton-X in PBS for 10 minutes. 
4. Rinse threads in PBS for 5 minutes. (2 times) 
5. Incubate threads in phalloidin stain (Alexa Fluor 488 phalloidin, Invitrogen Corp., 
A12379) for 30 minutes. se 2.5 μL of stock solution in 200 μL of PBS for each sample. 
Keep samples out of direct light from this point on. 
6. Rinse threads in PBS for 5 minutes. (3 times) 
7. Incubate threads in Hoechst dye (1:6000 dilution with dH2O) for 20 minutes. 
8. Rinse threads in PBS for 5 minutes. (2 times) 
9. Mount slides with aqueous mounting media or dehydrate samples and use Cytoseal (or 
another anhydrous mounting media). 
 
 
